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ABSTRACT 
 
Diabetes Mellitus, especially its most prevalent type, type 2 diabetes, is one of the most 
common and challenging chronic health problems, affecting an increasingly large part of 
the world population and continuing to increase considerably in numbers and significance. 
This metabolic disease affects substantially the quality of life, and its complications are 
main causes of morbidity and mortality.  
 
One of most frequent chronic complications associated with diabetes is diabetic peripheral 
neuropathy (DPN). This condition encompasses a wide variety of progressive peripheral 
nerve disorders induced by diabetes over time, affecting substantially proximal and distal 
peripheral sensory as well as motor nerves.  
 
The diagnosis and classification of neuropathy is usually based on a combination of 
neuropathic clinical symptoms, clinical signs and electrophysiological studies and findings. 
Additionally, other rigorous assessment techniques, such as nerve conduction studies and 
quantitative sensory testing are used in order to provide an extremely accurate diagnosis 
of peripheral neuropathy, being very useful in characterizing neuropathic expression. 
 
However, there is ample evidence that peripheral nerve abnormalities are directly 
connected to pathological changes in human corneas, showing also that diabetic 
neuropathies can be diagnosed and classified through computed analysis of corneal nerve 
morphology.  
 
In vivo corneal confocal microscopy (CCM) is increasingly used to acquire in vivo corneal 
nerve images, enabling real time examination of the living human cornea. This non-
invasive technique represents an ideal approach for research and clinical examination, 
producing high-quality images and visualizing the corneal layers, membranes and cells 
with high resolution.  
 
We present here a pilot study, aiming mainly to evaluate the ability of detecting and 
quantifying DPN, using the morphology of corneal nerves imaged by CCM. The study 
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consisted in a detailed evaluation of a small cohort of 12 healthy controls and 8 diabetic 
type 2 patients, divided according the presence/absence and severity degree of DPN.  
 
We have obtained promising results, similar to those obtained in prior research studies. 
The parameters that have shown diabetic neuropathy assessment potential were Nerve 
Fiber Density (NFD), Nerve Fiber Length (NFL), Nerve Fiber Width (NFW) and Nerve Branch 
Density (NBD). NFD, NFL and NBD are significantly lower in diabetics compared to controls 
(p <0.05), establishing inverse correlations with severity degree of DPN. NFW is increased 
in diabetics compared to controls (p <0.05), varying according to DPN severity. NFD and 
NFL revealed differences statistically significant (p <0.05) between no DPN cases and DPN 
patients, and most important, within diabetics (mild DPN and moderate DPN groups) and 
healthy controls.  
 
 
We found that CCM can be successfully used as complementing technique for the clinical 
and electrophysiological diagnosis of DPN, as defined by consensus criteria using nerve 
conduction studies. 
 
 
Keywords: diabetes, diabetic peripheral neuropathy, corneal confocal microscopy, corneal 
nerves, morphometric parameters. 
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RESUMO 
 
A Diabetes Mellitus, principalmente a Diabetes tipo 2, é uma das doenças crónicas mais 
prevalentes, e mais desafiantes. A diabetes atinge uma grande parte da população 
mundial, com este número a aumentar consideravelmente nos últimos anos. Esta doença 
metabólica afeta substancialmente a qualidade da vida, resultando em complicações 
graves, que são as principais causas da morbidez e mortalidade.  
 
Estão associadas à diabetes várias complicações crónicas. Uma das mais frequentes é a 
neuropatia diabética periférica (DPN) – a principal causa de incapacidade em diabéticos. 
Esta condição patológica inclui uma variedade de danos neurológicos periféricos, que são 
progressivos e que afetam principalmente os nervos sensitivos proximais e distais, bem 
como os nervos motores. 
 
O diagnóstico e a classificação da neuropatia é geralmente baseada numa combinação de 
sintomas clínicos e sinais neuropáticos, e em estudos electrofisiológicos. Adicionalmente, 
são utilizados outros métodos, como os estudos de condução nervosa (NCS) e os testes 
sensitivos quantitativos (QST). Estes métodos conferem maior exatidão ao diagnóstico 
efetuado por exame clínico, sendo extremamente úteis na caraterização da expressão 
neuropática. 
 
Estudos recentes mostraram que as anomalias dos nervos periféricos estão diretamente 
relacionadas com as alterações no plexo nervoso sub-basal corneano, sugerindo que a 
neuropatia periférica pode ser diagnosticada e avaliada através da análise morfométrica 
dos nervos da córnea. Esta abordagem tem recebido uma crescente atenção.  
 
A microscopia confocal da córnea (CCM) é uma técnica frequentemente utilizada para 
adquirir in vivo imagens dos nervos da córnea. Esta técnica é não-invasiva e permite a 
obtenção de imagens da córnea em tempo real. A microscopia confocal representa um 
método ideal para investigação e avaliação clínica, produzindo imagens com alta qualidade 
e permitindo a visualização das camadas e das células da córnea com uma resolução 
elevada. 
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Apresentamos Aqui um estudo piloto em que se avalia a deteção e classificação da 
neuropatia periférica através da análise morfométrica dos nervos da córnea. O estudo 
consiste numa avaliação pormenorizada dum pequeno grupo de 12 voluntários não-
diabéticos e 8 doentes diabéticos tipo 2, classificados consoante a presença e o grau de 
severidade da neuropatia. 
 
Os resultados que obtivemos são promissores e similares aos reportados em estudos 
anteriores. Os parâmetros Densidade de Fibras Nervosas (NFD), Comprimento de Fibras 
Nervosas (NFL), Largura de Fibras Nervosas (NFW) e Densidade de Branching de Nervos 
(NBD) apresentaram o melhor desempenho na avaliação da neuropatia diabética. Os 
valores de NFD, NFL e NBD são significativamente mais baixos (p <0.05) nos doentes 
diabéticos quando comparados com os controlos, e exibem correlações inversas com o 
grau de severidade da neuropatia. Os valores de NFW são significativamente superiores 
nos doentes diabéticos, variando com o grau de severidade da neuropatia. Os parâmetros 
NFD e NFL mostram diferenças estatisticamente significativas (p <0.05) entre os casos sem 
neuropatia e os doentes com neuropatia, mostrando também diferenças significativas (p 
<0.05) entre os grupos dos diabéticos (classificados consoante a severidade da 
neuropatia), diferenciando os grupos com grau ligeiro e moderado de neuropatia, do 
grupo de controlos não-diabéticos.  
 
Concluímos que a CCM pode ser utilizada com êxito para complementar os resultados de 
avaliação da neuropatia periférica, obtidos através de exames clínicos e electrofisiológicos. 
 
 
Palavras-Chave: diabetes, neuropatia diabética periférica, microscopia confocal da córnea, 
nervos da córnea, parâmetros morfométricos. 
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CHAPTER 1 – CORNEAL ANATOMY AND PHYSIOLOGY 
 
1.1 - The normal healthy human cornea 
 
The cornea is the most significant refractive medium in the eye, representing its optical 
window that is essential for humans to see. The lens and cornea are the main optical 
systems that focus entering light rays into an image upon the retina. The cornea has 
greater optical potency than the lens in focusing light, as the incoming rays are bent more 
in the transition from air into the cornea than they are when passing into or out of the lens 
[1, 2]. 
 
 
Figure 1 - The structure of the human eye [2]. 
 
The normal diameter of the adult cornea may vary between 10 - 13 mm. The surface of the 
cornea is curved so that the received light rays from a single point source hit the cornea at 
distinct angles and are bent different amounts, directing the light rays back to a point after 
emerging from the lens. When the object is situated in the center of the field of view, the 
corresponding image is centered on a specific area identified as the fovea centralis, the 
area of the retina that is responsible for the highest visual clarity. The image on the retina 
is inverted relative to the original light source and it is reversed right to left as well [1, 2]. 
 
The cornea’s most important tasks are to transmit and focus light onto the retina, 
contributing up to 75% of the eye’s total focusing power. This fundamental structure is 
Evaluation of Corneal Nerve Morphology for Detection and Follow-up of Diabetic Peripheral Neuropathy 
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also responsible for maintaining the intraocular pressure and providing a protective 
interface with the environment. The cornea act effectively as a shield against germs, dust 
and other detrimental matter, acting additionally as a filter and protecting the retina 
against UV-B and UV-C radiation [1, 3-5]. 
 
 
1.1.1 - Macroscopic corneal anatomy 
 
The corneal tissue is positioned at the front of the eye. This connective, transparent and 
avascular structure is also one of the most densely innervated tissues in the human body, 
being abundantly supplied by sensory and autonomic nerve fibers [1]. 
 
Corneal transparency is mostly due to several factors, such as the homogeneous 
arrangement of the lamellae of collagen fibrils in the corneal stroma and the extremely 
smooth endothelial and epithelial surface produced by the intraocular pressure. Other 
factor that seriously influences the transparency is the water content of the corneal 
stroma. The dual action of the epithelium and endothelium maintains constant the water 
content at 70% [3-5]. 
 
The surface of the cornea consists in a stratified non-keratinized squamous epithelium that 
regenerates rapidly when injured. Epithelial defects are rapidly closed (within 1 hour) by 
cell migration and quick cell division [1]. 
 
Similarly to lens, sclera and vitreous body, the cornea is a bradytrophic tissue structure. It 
is nourished with nutritive metabolites, such as amino acids and glucose. These nutrients 
are delivered through diffusion processes from three sources: the capillaries at its edge, 
the aqueous humor and the tear film [1]. 
 
The corneal tissue consists of five distinct avascular layers: the epithelium, the Bowman’s 
layer, the stroma, the Descemet’s membrane and the endothelium. Each of these layers 
plays a particular role in cornea [1]. 
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Figure 2 - Anatomy of the cornea [1]. 
 
 
1.1.2 - Corneal epithelium 
 
The corneal epithelium is constantly maintained by the balance between permanent cell 
loss by shedding of surface epithelium, and regular cell substitution by proliferation of 
basal epithelial cells [1]. This layer contains numerous tiny nerve endings, which makes the 
cornea extremely sensitive to the slightest touching. Adjacent cells are joined 
circumferentially, acting as a semi-permeable membrane and giving the surface epithelium 
its blocking barrier function against invasion by pathogens or other foreign material. 
Epithelial permeability level normally increases with age, exposing the cornea to possible 
infections [3-5].  
 
 
1.1.3 - Bowman’s layer 
 
Bowman’s layer is an acellular and transparent lamella of tissue, consisting of arbitrarily 
oriented, closely packed collagen fibrils, and being placed right below the epithelium [1]. 
This layer is very resistant but cannot regenerate following wounds. Consequently, injuries 
to Bowman’s layer usually cause corneal scarring, which could seriously affect the vision. 
This layer contains several nerves, that branch to form a basal epithelial nerve plexus. 
These nerves are rapidly and easily identified by confocal microscopy [3-5]. 
Evaluation of Corneal Nerve Morphology for Detection and Follow-up of Diabetic Peripheral Neuropathy 
5 
 
1.1.4 - Corneal stroma 
 
Beneath Bowman’s layer, many collagen fibrils form the corneal stroma. This avascular, 
transparent and highly bradytrophic tissue, is the largest corneal layer [1]. Its avascularity 
makes it an immunologically advantaged site for grafting, while the collagen gives the 
cornea its essential properties: elasticity, strength and form. It has been alleged that 
corneal light-conducting transparency is the effect of the regular spatial arrangement of 
collagen fibrils. The stroma also contains large nerves and fibroblasts, which are generally 
nominated as stromal keratocytes [3-5].  
 
 
1.1.5 - Descemet’s membrane 
 
Descemet’s membrane and the corneal endothelium lie on the posterior surface of the 
corneal stroma. Descemet’s membrane is a relatively strong and resistant membrane. 
Formed by collagen fibers and endothelial cells, this membrane is a valuable shield against 
infection and injuries [1, 3-5]. 
 
 
1.1.6 - Corneal endothelium 
 
The corneal endothelium is composed by a single layer of flattened endothelial cells. This 
intern cell membrane is essential for the prevention of stromal swelling, maintaining a 
relative condition of deturgescence [1, 2]. This is due to the barrier and pump functions of 
these cells, which are the most metabolically active cells in the cornea. Oxygen and 
necessary nutrients are supplied by the aqueous humour. The corneal endothelial cells do 
not regenerate, leading to a decreased density directly related with ageing. A declined 
density can result in a lack of hydration regulation, leading to transparency loss [2-4].  
 
 
1.1.7 - Limbus 
 
The limbus is the junction between the cornea and sclera [1]. This structure may be 
subdivided into two anatomical parts: the corneal limbus and the scleral limbus. The 
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corneal limbus is clearly distinguished by a line joining both terminations of Bowman’s 
layer and Descemet’s membrane. Patel [4] has reported that the corneo-scleral limbus 
plays a decisive role in the maintenance of corneal epithelial integrity, providing epithelial 
self-renewing stem cells [2-4]. 
 
 
1.2 – Corneal nerves 
 
The human cornea is a vital and remarkably sensitive structure of the eye [1]. Extremely 
slight tactile sensation may cause an eye closing reflex [2]. Cornea receives its plentiful 
sensory supply from the ophthalmic and maxillary division of the trigeminal nerve. Most 
sensory nerves lose the myelin sheath and perineurium, branching into smaller nerves. 
These smaller branches will perforate the cornea and form the corneal nerves, which have 
multiple sensory and efferent functions [5, 7].  
 
Any mechanical, thermal or chemical stimulation of the corneal sensory nerves results 
principally in sensation of pain. Corneal sensation is necessary for keeping the integrity of 
the ocular surface. The smallest damage to the cornea, such as erosion, foreign-body 
penetration, or ultraviolet keratoconjunctivitis, may significantly affect the tissue, exposing 
sensory nerve endings and causing severe pain with reflexive tearing and unintentional 
eye closing [5-7]. 
 
Muller et al. [5], affirmed that nerve fiber bundles in the sub-basal plexus continue first in 
the 3–9 o'clock hours direction, then turn abruptly by 90° and extend in the 6–12 o'clock 
hours direction. After a second abrupt bifurcation, nerve fibers follow in the 3–9 o'clock 
hours direction. Nevertheless, current human studies with in vivo confocal microscopy 
(IVCM) propose a different model of central sub-basal corneal innervation, where most 
leashes of nerve fibers follow through the corneal apex preferentially in the 6–12 o'clock 
direction, while other leashes approach the apex in different directions. However, due to 
technical reasons, IVCM images are limited mainly to the corneal apex and cover a 
reduced area of the central cornea. As a result, the orientation of sub-basal nerves in 
peripheral regions of the human cornea continues partly unrevealed [5]. 
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CHAPTER 2 – DIABETES MELLITUS 
 
2.1 – Definition, characteristics and impact 
 
Diabetes Mellitus is one of the most common and challenging chronic health problems [8]. 
This metabolic disease affects a large part of the world population and continues to 
increase considerably in numbers and significance [9].  
 
Diabetes is characterized by uncontrolled chronically rising levels of blood glucose caused 
by a deficiency in insulin secretion and/or insulin resistance (depending on its’ type), 
resulting in the incapacity of the insulin hormone in transforming the glucose [10]. 
 
The prevalence of diabetes (principally type 2) is increasing due to demographic changes, 
such as population growth, ageing and especially better care health, improving longevity 
of patients with diabetes. Economic development and urbanization lead to changing 
sedentary lifestyles characterized by decreased physical activity and increased obesity, 
extremely detrimental for human health [9, 10]. 
 
Consequently, the prevalence of this metabolic disease has developed to epidemic 
proportions with a population that is now overweight and obese. According to several 
clinical reports and data sources [9], approximately 366 million people had diabetes in 
2011. The number is expected to increase up to 552 million by 2030, corresponding to a 
50.7 % increase in worldwide adult population with diabetes [9, 10].  
 
The pattern of diabetes show significant differences in developed countries, where most 
population with diabetes are aged over 60 years, when compared with developing 
countries, where the majority with diabetes are of working age, varying between 40 and 
60 years. This discrepancy is expected to remain present in 2030, although less noticeable, 
as the average age of developing countries’ populations is estimated to increase a little 
more than in the developed countries [9]. 
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2.2 – Diabetes types 
 
There are two major types of diabetes: type 1 and type 2 (described below). A different, 
but well-known type is the gestational diabetes, a condition that develops only during 
pregnancy. Several other types of diabetes, previously known as secondary diabetes, are 
mainly caused by other illnesses or medications [11, 12]. 
 
 
2.2.1 – Type 1 
 
Type 1 diabetes, also known as insulin-dependent diabetes or juvenile-onset diabetes, 
includes those cases attributable to an autoimmune disorder, associated to a massive 
destruction of the insulin-producing beta cells in the pancreas. Patients with type 1 
diabetes show total insulin insufficiency and generally require insulin early in the disease 
[9].  
 
It can occur at all ages, but normally presents at young age, encompassing the most part of 
cases which are primarily due to pancreatic islet beta–cell destruction or reveal 
ketoacidosis [9, 11]. Its occurrence reveals obvious geographical differences and is mainly 
common in Caucasians in Finland, Denmark, Norway, Sweden and Sardinia [13]. 
 
 
2.2.2 – Type 2 
 
Type 2 diabetes represents the common major form of diabetes, accounting for 
approximately 95% of diagnosed cases of diabetes worldwide. It results principally from 
relative (rarely absolute) insulin deficiency and defects in insulin secretion, usually 
connected to insulin resistance [12]. Consequently, there is insufficient insulin to 
completely compensate for the insulin resistance. Most people with this form of diabetes 
are sedentary and obese, and the obesity leads to a certain degree of insulin resistance. 
This type is also called non-insulin-dependent diabetes or adult-onset diabetes [12, 13]. 
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Type 2 diabetes occurrence varies significantly between countries and ethnic groups, 
varying between 5–8% in Europe. The top 10 countries, in numbers of patients with 
diabetes, are at the moment India, China, the United States, Indonesia, Japan, Pakistan, 
Russia, Brazil, Italy, and Bangladesh [9, 11].  
 
Type 2 diabetes mellitus prevails mostly among Hispanics, Native Americans, African 
Americans, and Asians/Pacific Islanders than in non-Hispanic whites. Undeniably, this 
disease is becoming practically pandemic in several groups of Native Americans and 
Hispanic people. Type 2 diabetes usually has a later age of onset, but a frightening increase 
in the occurrence of this form among adolescents and children has been reported by 
numerous clinical sources [11-13]. 
 
 
2.2.3 – Gestational diabetes 
 
Gestational diabetes represents a carbohydrate intolerance, followed by hyperglycemia of 
different severity degrees with onset only during pregnancy. In many cases glucose 
intolerance may be previously unrecognized and precede pregnancy. The definition 
remains valid and irrespective of whether or not insulin is used for treatment or if the 
disease continues after pregnancy [13]. 
 
 
2.2.4 – Other causes of diabetes 
 
Other specific forms are at the moment less common causes of Diabetes Mellitus, but are 
those in which the underlying factor can be identified in a relatively precise way. These 
types of diabetes generally depend on the primary process involved, such as destruction of 
pancreatic beta cells or development of peripheral insulin resistance [13].  
 
These types of diabetes have many similarities with type 1 or type 2 diabetes. Most 
prevalent forms are associated with pancreas complications, such as hemochromatosis, 
pancreatitis, cystic fibrosis and pancreatic cancer. These types are often caused by 
hormonal syndromes, which severely interfere with insulin secretion, such as 
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pheochromocytoma, or induce peripheral insulin resistance, such as acromegaly, Cushing 
syndrome and pheochromocytoma. Diabetes is increasingly caused by drugs, for example 
phenytoin, glucocorticoids or estrogens [12, 13]. 
 
 
2.3 – Consequences of diabetes 
 
Diabetes represents an enormous problem. Its high prevalence is largely attributed to type 
2 diabetes, resulting in considerably increasing health care costs. This disease usually leads 
to other pathologies; its effects comprise long–term damage, dysfunction and failure of 
distinct organs. People with diabetes have a substantially higher probability to 
progressively develop cardiovascular, peripheral vascular and cerebrovascular diseases [8, 
11].  
 
Diabetes affects substantially the quality of life, and its complications are main causes of 
morbidity and mortality. The complications encompass both micro-vascular (neuropathy, 
nephropathy, and retinopathy) and macro-vascular (atherosclerotic) disease. It is the 
major initiating cause for foot ulceration, Charcot’s neuroarthropathy and lower extremity 
amputation [11-12]. 
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CHAPTER 3 – DIABETIC NEUROPATHY 
 
3.1 – Definition of diabetic neuropathy 
 
Diabetic neuropathy is among the commonest long-term complications of diabetes, 
representing the main cause of chronic disability in diabetic patients. This condition 
encompasses a large spectrum of nerve disorders induced by diabetes over time, leading 
to the development of nerve damage throughout the human body [10, 11].  
 
Peripheral nerve involvement is extremely frequent in diabetes mellitus and it has been 
revealed that neuropathy is estimated to be present in approximately 8% of newly 
diagnosed diabetic patients [14].  
 
According to members of international consensus meeting on diagnosis and management 
of diabetic neuropathy, this complication can be defined as the obvious presence of 
symptoms and signs of peripheral nerve dysfunction, either clinically evident or subclinical, 
that occurs in the setting of diabetes after the exclusion of other causes. This disorder 
comprises the manifestations in the somatic and/or autonomic parts of peripheral nervous 
system [15]. 
 
It is developed by more than 50% of the patients with long-standing disease within 25 
years of diagnosis [14]. The prevalence of diabetic neuropathies is dramatically increasing 
with the enormous burden of type 2 diabetes, but the true occurrence remains 
unrevealed, with variable reports in diabetic patients depending mostly on the criteria and 
methods used to identify neuropathy [15, 16].  
 
Some patients with nerve damage have no symptoms, whilst most part have extremely 
painful symptoms, such as burning pain, squeezing, constricting, freezing, allodynia or non-
painful neuropathic deficits, such as asleep, tingling, numbness—loss of feeling—in the 
hands, arms, feet, and legs [11, 14].  
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Nerve complications can easily occur in different organ systems, including the digestive 
tract and cardiovascular system. In long term, unrevealed and untreated neuropathy is the 
main cause of foot infections that not heal, foot ulcers followed in many cases by 
inevitable amputation. Diabetic neuropathy is associated to 50-75% of non-traumatic 
amputations [14, 17]. 
 
 
3.2 – Pathogenesis and etiology of diabetic neuropathy 
 
According to Vinik et al. [14], diabetic neuropathy is among the least recognized and 
understood complications of diabetes despite its considerable negative impact on survival 
and quality of life. 
 
Despite latest knowledge about pathophysiological mechanisms for numerous of the long 
term complications of diabetes, the exact pathogenesis of diabetic neuropathy continues 
unrevealed. Different multi-factorial mechanisms have been proposed to explain 
pathogenesis of diabetic neuropathy, but none has achieved general acceptance and 
approval [14, 16]. 
 
Risk factors for its development comprise diabetes duration, degree of hyperglycemia, 
hyperlipidemia, hypertension, and height. Retinopathy and nephropathy are highly 
associated with peripheral neuropathy, occurring in approximately 55% and 32% of type 1 
and type 2 diabetic patients, respectively [11, 15]. 
 
Hypotheses regarding the multiple etiologies of diabetic neuropathy include a wide range 
of metabolic injuries to nerve fibers and vascular/ischemic sources. Autoimmune factors 
are also thought to play an essential role in the development of this nerve disorder. Main 
pathophysiological factors and mechanisms are summarized in Table 1 [11, 16]. 
 
In addition, neuro-hormonal growth factor lack, nutritional deficiencies and hereditary 
factors can lead to this disease. Often the condition is idiopathic, as no cause can be 
detected [11, 16]. 
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Table 1 - Classification of physiopathological factors of diabetic neuropathy [11]. 
 
Metabolic 
Polyol pathway (aldose reductase) 
Glycosylation of essential proteins (glycation end products) 
Free radicals and oxidative stress 
Neuronal growth factors and insulin deficiency 
Vascular/Ischemic 
Basement membrane reduplication in vasa nervorum 
Reduced endoneurial blood flow 
Reduced endoneurial oxygen tension 
Autoimmune 
Auto-antibodies against adrenal medulla, sympathetic 
ganglia and vagal nerve 
Autonomic ganglia infiltrated by immune cells 
Calcium-dependent apoptosis of neuronal cells 
 
 
 
3.2.1- Metabolic nerve injuries 
 
Hyperglycemia 
 
Among the metabolic factors, hyperglycemia is doubtless the most frequent initiating 
factor. In hyperglycemia, excess of glucose is transformed to sorbitol via the enzyme 
aldose reductase (through the polyol pathway) leading to accumulation of sorbitol and 
reduction of myo-inositol in nerve tissue. This usually results in large nerve damages, 
which can happen at very early stages of diabetes. It has been suggested that duration and 
severity of exposure to hyperglycemia has a great impact on the severity degree of 
diabetic neuropathy [15, 16].   
 
Polyol pathway 
 
Hyperglycemic activation of polyol pathway may lead to significant changes in the 
NAD/NADH ratio, leading to direct neuronal injury and/or decreased nerve blood flow. 
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Increased glucose flux through the polyol pathways induces frequently peripheral nerve 
damages and modifications to the crystalline lens in the eye. In experimental studies, 
these metabolic alterations stimulate osmotic swelling and variation in sodium-potassium 
ATPase activity in diabetic nerves. A decrease in sodium-potassium ATPase activity can be 
associated to slowing of nerve conduction velocity [15, 16]. 
 
 
Oxidative stress 
 
Diabetes induces a substantial increase in the concentration of intracellular of glucose 
content, leading to a more intensive interaction between glucose and reactive oxygen 
species, which results in increased extracellular osmotic stress [14, 15].  
 
Oxidative stress generally affects mitochondrial permeability, which activates the 
programmed cell death caspase pathways, inducing apoptosis of neurons and Schwann 
cells. Several neuronal growth factors and insulin itself promote survival and outgrowth of 
neurons. Nevertheless, due to apoptosis, the nerve regeneration is frequently impaired 
and signaling from the growth factors fails, causing irreversible permanent nerve damages 
and leading to peripheral neuropathy [15, 16]. 
 
 
3.2.2 - Vascular/Ischemic nerve injuries 
 
In the past years, diabetic peripheral neuropathy has been often associated with micro-
vascular complications. Microangiopathy with endothelial dysfunction of the vasa 
nervorum is considered the main vascular factor causing conditions of ischemia and 
hypoxia in nerves of diabetic patients [11, 15].  
 
Recent pathological studies of sural nerves of diabetic patients reveal several alterations, 
counting thickening of the endoneurial capillary basement membrane, capillary closure, 
endothelial cell hypertrophy and hyperplasia, and pericyte degeneration [11, 16].  
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Impaired vasodilatation of the vasa nervorum may lead to early and significant 
microangiopathic alterations, consequently causing narrowing of the capillary lumen, 
resulting in decreased capillary blood flow, hypoxia. This promotes a fast progression of 
neuropathy, accompanied by a gradual degeneration of myelinated and unmyelinated 
nerve fibers [11, 16]. 
 
As previously described, main factors are classified into two major subgroups: 
abnormalities involved in metabolic etiology and abnormalities that suggest a vascular 
etiology. Table 2 summarizes the hypothesis implicated in the pathogenesis of diabetic 
neuropathy [16].  
 
 
Table 2 - Most common abnormalities implicated in the pathogenesis of diabetic 
neuropathy (according to the two major proposed sub-groups) [16]. 
 
Vascular etiology Metabolic etiology 
Hyperglycemia Hyperglycemia/hypoinsulinemia 
Increased endoneural vascular resistance Dyslipidaemia 
Decreased nerve blood flow Increased aldose reductase activity 
Endothelial dysfunction Decreased nerve Na/K ATP-ase 
Advanced glycation of vessel wall 
Decreased rate of synthesis and transport 
of intra-axonal proteins 
Basement membrane thickening Increased glycogen accumulation 
Endothelial cell swelling and pericyte 
degeneration 
Increased monoenzymatic peripheral nerve 
protein glycosylation 
Closed and collapsed capillaries 
Decreased incorporation into myelin of 
glycolipids and aminoacids 
Occlusive platelet thrombi Abnormal inositol lipids metabolism 
Epineural vessel atherosclerosis Decreased nerve L-carnitine level 
Increased oxygen free radicals activity Increased protein kinase C activity 
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3.2.3 – Autoimmune nerve injuries 
 
Diabetic neuropathy pathogenesis involves triggers that may activate different 
autoimmune mechanisms in susceptible individuals. Numerous studies suggest that 
autoimmune activation in both type 1 and type 2 diabetes results from the reaction of 
circulating antibodies with nervous autonomic tissue [15, 16].  
 
Despite latest provided information, it is not clearly understood whether autoimmunity 
plays a major role in the pathogenesis; more probable, it accelerates peripheral 
neuropathy promoted by metabolic or vascular injuries. Autoimmune mechanisms may 
accompany hyperglycemia in order to progressively damage sensory and/or autonomic 
neurons [15, 16]. 
 
 
3.3 - Classification and characteristics of diabetic neuropathy  
 
Diabetic neuropathy is a descriptive term that includes a wide variety of abnormalities 
affecting substantially proximal and distal peripheral sensory as well as motor nerves and 
the autonomic nervous system. Simplest anatomical classification includes single 
(mononeuropathy), several (mononeuropathy multiplex) or general multiple nerve 
damages (polyneuropathy) [17, 18].  
 
More detailed classification comprises numerous clinical and subclinical syndromes, which 
are known to be heterogeneous by their distinct anatomical distributions, symptoms, 
pattern of neurological involvement, clinical courses, risk covariates, pathological 
alterations, and certainly differing primary causes and underlying mechanisms [17]. Each 
syndrome can be characterized by diffuse or focal damages to peripheral somatic or 
autonomic nerve fibers, even though some indistinguishable cases may occur idiopathic or 
develop with other disorders in patients without diabetes mellitus.  These are summarized 
in Table 3 [17-19].  
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Table 3 - Classification of diabetic neuropathy [17, 19]. 
 
Type of diabetic neuropathy Sub-types 
Rapidly reversible Hyperglycemic neuropathy 
Distal symmetrical polyneuropathies 
(DSPN), (can occur with/without 
DAN) 
Distal sensori-motor (chronic) polyneuropathy: 
 Small fiber 
 Large fiber 
 Mixed 
 
Acute (painful) sensory polyneuropathy variants 
 
Diabetic autonomic neuropathy 
(DAN): 
Abnormal pupillary function 
Sudomotor dysfunction 
Genitourinary 
Gastrointestinal 
Cardiovascular 
Hypoglycemia unawareness 
Focal and multifocal neuropathies 
Mononeuropathy 
Mononeuropathy multiplex 
Plexopathy 
Cranial neuropathy 
Thoracolumbar radiculoneuropathy 
Focal limb neuropathy 
Lumbosacral radiculoplexus neuropathy 
Superimposed chronic inflammatory 
demyelinating neuropathy 
N/A 
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3.3.1 – Diabetic distal symmetrical polyneuropathy (DSPN) 
 
DSPN is by far the most frequent of all diabetic neuropathies, affecting sensory more than 
motor nerves. This condition is mainly axonal with a mixed large - and small diameter 
nerve fiber involvement [16, 17]. Confirmation is normally achieved by nerve conduction 
studies (NCS). Axonal loss results in decreased amplitudes of the compound muscle action 
potential (CMAP) and sensory nerve action potential (SNAP). Demyelination cases are 
typically characterized by reduced nerve conduction velocity (NCV) and dispersion [16-20].  
 
The predominantly large-fiber type symmetric polyneuropathies are principally 
characterized by loss of ankle reflexes, reduced position and vibratory senses, cold thermal 
perception and sensory ataxia. Large-fiber neuropathies may affect both sensory and 
motor nerves. These tend to be the neuropathies of signs rather than symptoms. 
Contrasting the small fibers, these are myelinated and fast conducting fibers. They appear 
to be affected first mostly due to their length and the predisposition in diabetes for nerves 
to “die back” (phenomena characterized by large extent of axon retraction)[16, 17]. 
 
DSPN represents a paradox: at one extreme there are patients with extremely painful 
neuropathic symptoms who on examination may have only a smallest deficit, whereas at 
the other extreme are patients with insensate feet who are asymptomatic and may initially 
reveal with foot ulcers. This neuropathy is an independent risk factor for mortality and 
morbidity as a result of foot ulceration and amputation [17, 18]. 
 
DSPN may be divided into the following two major types: acute sensory (atypical) 
neuropathy and chronic sensorimotor (typical) neuropathy [18]. 
 
Chronic sensorimotor neuropathy is thought to be the commonest variety of diabetic 
polyneuropathy, as reported from cohort and population-based epidemiological studies. 
Usually develops on a background of long-lasting chronic hyperglycemia, associated 
metabolic disorders and cardiovascular risk factors. Metabolic derangements that are also 
involved in the development include polyol shunting, accumulation of advanced glycation 
end products, oxidative stress, lipid abnormalities and micro-vessel alterations [18, 20].  
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Chronic neuropathy is regularly of severe onset and may affect up to 10% of patients with 
diabetes at the moment of diagnosis. Whereas up to 50% of patients with chronic 
neuropathy may be asymptomatic, 10–20% may experience worrying symptoms sufficient 
to justify specific treatment. This type is frequently accompanied by autonomic 
dysfunction. Its late damage, which encompasses foot ulceration, followed often by 
amputation, should in many cases be possible to prevent [18, 20].  
 
The prevalence of chronic neuropathy increases with both age and duration of diabetes, 
and its diagnosis is more frequent in those whose glycemic control has been suboptimal in 
preceding years. An abnormality of nerve conduction, which is in many cases occurs 
without signs or symptoms of polyneuropathy, appears to be the first objective and 
quantitative indication necessary to confirm the diagnosis of this increasingly frequent 
form of polyneuropathy [18, 20]. 
 
Acute sensory neuropathy is a type characterized by acute or subacute onset associated 
with insidious sensory symptoms, typically with a small number of clinical signs. It differs 
from typical polyneuropathy in several significant features, such as onset, clinical course, 
manifestations, associations, and sometimes putative mechanisms [18, 20]. 
 
This atypical form can develop at any time during the life of a patient with diabetes 
mellitus. Onset of symptoms may be acute, subacute, or chronic, but the course is 
habitually monophasic or variable over time. It is usually caused by glycemic instability, 
such as ketoacidosis or even after the administration of insulin. Its symptoms improve 
gradually with the establishment of regular glycemic control and conventional 
symptomatic therapies [18, 20]. 
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3. 3. 2 - Diabetic autonomic neuropathy (DAN) 
 
DAN is a subtype of the peripheral polyneuropathies that accompany diabetes, being one 
of the least recognized and understood complications of diabetes regardless of its 
considerable negative impact on survival and quality of life. Little is known about the 
epidemiology of this form in the different types of diabetes and much continues to be 
learned about its natural clinical course [21]. 
 
The reported prevalence of DAN is variable, depending on the type and number of tests 
performed and the presence or absence of signs and symptoms of autonomic neuropathy. 
The variance results from the different studies that have been carried out in the 
community, clinic, or tertiary referral center. Other causes that can be considered for the 
marked variability in reported prevalence rates comprise the lack of a standard definition 
of DAN, different diagnostic methods, variable study selection criteria, and referral bias. 
Additionally, the establishment of a more precise estimative is influenced by the existence 
of other confusing factors, like the wide diversity of clinical syndromes and confounding 
variables such as age, sex, duration of diabetes, glycemic control, diabetes type, and 
height [22]. 
 
Dysfunction of the autonomic nervous system it has been reported in about 20 to 40% of 
diabetics and it is not simply an “all or none” phenomenon. Diabetic autonomic 
neuropathy usually manifests first in longer nerves and occurs as a system-wide disorder 
involving the entire autonomic nervous system (ANS) [21, 22]. 
 
This condition affects significantly the vasomotor, visceromotor and sensory fibers that 
innervate every organ. Several organs are dually innervated, receiving an ample fibre 
supply from the parasympathetic and sympathetic divisions of the ANS. As a result, DAN is 
manifested by dysfunction of one or more organ systems, such cardiovascular, 
gastrointestinal, genitourinary, sudomotor or ocular [22]. 
 
Clinical manifestations of autonomic dysfunction and other micro-vascular complications 
frequently occur concurrently but in undistinguishable patterns. Clinical symptoms of 
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autonomic neuropathy usually occur long time after the onset of diabetes. Whereas 
symptoms revealing the autonomic dysfunction may be frequent they may often be due to 
other disorders rather than to true autonomic neuropathy. Subclinical autonomic 
dysfunction can, however, manifest within a year of diagnosis in type 2 diabetes patients 
and within two years in type 1 diabetes patients [22]. 
 
 
 
3.3.3 – Focal and multifocal neuropathies 
 
This group should not be considered a separated type, as they frequently co-exist with 
DSPN.  Their etiologies are possible to differ, as these disorders have predominantly a 
vascular component or a compressive etiology, contrasting with the prominent metabolic 
component in DSPN. Factors that cause the development of the compression neuropathies 
are related to either the peripheral nerve itself or the structures adjacent to the point of 
compression [19, 23]. 
 
This group of rare neuropathies includes the following types: mononeuropathies (carpal 
tunnel syndrome, ulnar neuropathy, radial neuropathy, common peroneal neuropathy, 
and lateral femoral cutaneous neuropathy), cranial neuropathies (ocular neuropathies, 
facial neuropathies), diabetic amyotrophy and diabetic truncal neuropathy [23]. 
 
 
Carpal tunnel syndrome is the commonest entrapment neuropathy detected in diabetic 
subjects. It occurs as a result of median nerve compression under the transverse carpal 
ligament. Idiopathic carpal tunnel syndrome can be encountered in patients with 
rheumatoid arthritis, hypothyroidism, and obesity. In about 30% of diabetic patients, it can 
be diagnosed electrophysiologically, but represents a clinically significant problem in 
approximately 6% of diabetic subjects [23, 24]. 
 
Ulnar neuropathy is another frequent entrapment neuropathy (2.1%), occurring principally 
as a result of ulnar nerve compression in the cubital tunnel. It may also develop as a 
consequence of deformity at the elbow joint secondary to fracture or as a consequence of 
prolonged pressure during surgery. This disorder is often associated with alcoholism. 
Evaluation of Corneal Nerve Morphology for Detection and Follow-up of Diabetic Peripheral Neuropathy 
22 
 
Typical symptoms are painful paresthesiae in the fourth and fifth digits related with 
hypothenar and interosseous muscle wasting [23, 25]. 
 
Radial neuropathy occurs rarely (0.6%), as a result of radial nerve compression in the spiral 
groove. This type reveals characteristic motor deficits of wrist drop with extremely rare 
sensory symptoms of paresthesiae in the dermatomes supplied by the superficial radial 
nerve. Main causes of idiopathic radial neuropathy are humeral fracture, blunt trauma 
over the posterolateral aspect of the arm, and external compression [23, 26]. 
 
In the case of cranial ocular neuropathies, cranial nerves III, IV, and VI are mainly affected. 
Among diabetic patients, the relative injure frequency is greater for oculomotor and 
abducent nerves (3.3%), while for the trochlear nerve is smaller (2.1%). The causal 
pathology and pathogenesis of this type remains incompletely understood, due to the 
difficulties in obtaining tissue in such patients. Nevertheless, several studies postulate that 
focal demyelination occurs as consequence of ischemia [23, 27]. 
 
The typical presentation of oculomotor nerve palsy consists in an acute onset of diplopia, 
followed by papillary sparing related with ipsilateral headache. Pupillary sparing is often 
used for differentiating diabetic from other structural ophthalmoplegias (such as 
aneurysm, tumor, or mass). Approximately 14 – 18% of diabetic subjects reveal pupillary 
dysfunction [23, 27]. 
 
 
 
3.4 – Diagnosis of diabetic neuropathy 
 
In the past years, detection of DPN has been difficult, for the reason that this disorder 
affects a broad variety of nerve fibers. For diagnosis is necessary to identify and assess 
various features of neuropathy [28]. 
 
In general, experienced physicians can diagnose and systematically assess neuropathic 
signs and symptoms of peripheral neuropathy, involving sensory, motor and reflex 
measures of upper and lower extremities, cranial nerves and autonomic function [19].  
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The diagnosis of diabetic neuropathy implies also the exclusion of non-diabetic causes, 
such as metabolic, hereditary, nutritional deficiency, immunological, and toxic causes [19, 
28], all explained in Section III, Chapter 6.  
 
Although trained neurologists can diagnose neuropathy with a clinical examination, an 
enormous discrepancy in diagnostic criteria exists in the literature. The American Academy 
of Neurology in conjunction with the American Association of Electrodiagnostical Medicine 
and the American Academy of Physical Medicine and Rehabilitation established general 
rules and definitions in order to standardize and facilitate clinical research and 
epidemiologic studies [14, 29]. 
 
Accordingly, to obtain a precise diagnose and classification of neuropathy, usually it is 
required a combination of neuropathic clinical symptoms, clinical signs and 
electrophysiological studies and findings. Quantitative sensory testing (QST) and 
autonomic function testing are used in order to provide an extremely accurate diagnosis of 
peripheral neuropathy, being very useful in characterizing neuropathic expression [28, 29]. 
 
Additionally, other rigorous assessment techniques such as NCS, sural nerve biopsy, skin 
biopsy for evaluation of intra-epidermal nerve fibers, can be performed using appropriate 
testing conditions, suitable criteria and reference values to address well-defined clinical or 
research questions [28, 30] 
 
 
3.4.1 - Clinical examination of DPN 
 
Currently, screening for neuropathy is normally performed during a patient’s routine 
clinical examinations. Recommendations and suggestions for screening, follow-up and 
management of this problematic nerve disorder are included in the International 
Guidelines for Diagnosis and Outpatient Management of DPN and are presented in Table 4 
[28, 31]. It is important to mention that these guidelines were rigorously followed during 
all clinical examinations of our study. 
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Table 4 - Guidelines for Diagnosis and Outpatient Management of DPN [28]. 
Annual Review Assessment 
Patient history 
Age, diabetes, physical factors, lifestyle, 
social circumstances, symptoms, other 
possible etiological factors 
Examination of both feet 
Skin status, sweating, infections, ulceration, 
calluses/blistering, deformity, muscle 
wasting, arches, palpitation for 
temperature, pulses, joint mobility 
Vascular examination Check foot pulses 
Other 
Thyroid function to exclude other etiologies 
for neuropathy, presence or absence of 
characteristics of the “at-risk foot” 
 
In most cases, a simple clinical examination is a fine predictor of future foot ulceration, 
detecting typically a symmetrical sensory loss. The feet are normally examined for ulcers, 
calluses and deformities [32-34]. 
 
The clinical examination includes several tests of peripheral sensation, tendon reflexes, 
and muscle strength. Neuropathic symptoms with distal sensory loss, absent tendon 
reflexes, and abnormal nerve conduction studies are highly suggestive of diabetic 
neuropathy [14, 31].  
 
Diabetic patients have frequently difficulties in describing the symptoms of neuropathy, as 
they are different than the usual pain that they have before experienced. There is an 
obvious variation in the description of symptoms between persons with similar 
pathological injuries. When evaluating symptoms in clinical practice, doctors must not 
“interpret” or “translate” patient reports; instead, they should record accurately the 
patient’s description word for word [31-34]. 
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3.4.2 - Scoring of signs and symptoms in DPN 
 
In the last decades, several scoring systems have been proposed to quantify clinically 
neurological deficits and consequently, identify the presence of neuropathy and also 
classify its severity degree. Each scoring system has its specific scheme, based on particular 
scoring scale [28, 32].  
 
 
Neuropathy Disability Score  
 
This approach for assessing the clinical signs was originally pioneered by Dyck et al. [35] in 
the Mayo Clinic, who described the Neuropathy Disability Score (NDS). They designed an 
efficient scheme to detect and grade diabetic peripheral neuropathy. 
 
In the NDS, impairment of sensation to pain, vibration and joint position, muscle strength 
in the face, torso and extremities, tendon reflexes of the upper and lower extremities are 
separately scored, and all scores are summed to give a compound score of neurological 
deficits [35]. Based on a scale of 0-4 (0 = no deficit, 1 = mild deficit, 2 = moderate deficit, 3 
= severe deficit, and 4 = complete absence of function or the most severe deficit), this 
grading system may be used in epidemiological studies and clinical trials, as well as in 
clinical practice [32, 35]. 
 
Although it provides an accurate, comprehensive and reproducible measure of the severity 
of diabetic neuropathy, this scoring system requires a well-trained neurologist who can 
correctly assess muscle strength and grade the severity of sensory deficits, limiting the role 
of this valuable research tool in daily clinical practice [35, 36]. 
 
 
Modified Neuropathy Disability Score 
 
A modified NDS has been used in many important studies and has been reported as 
predictor for future foot ulceration. This method, first described by Young et al. [38], can 
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be definitely performed by a non-specialist, providing a sum of the sensory and reflex 
deficits [37, 38].  
 
The sensory score derives from a complete evaluation, including pain (pin prick), touch 
(cotton wool), cold (tuning fork immersed in icy water), and vibration (128 Hz tuning fork).  
Each modality is scored from 0 to 5, according to the anatomical level at which sensation is 
affected. The average of both feet is calculated and the total of all four deficits represent 
the sensory score [32, 38].  
 
The reflex score is obtained from the knee and ankle reflexes on a scale from 0 to 2 (0 = 
normal, 1 = elicited with reinforcement and 2 = absent). A final score from 1 to 5 
represents a mild degree, 6–16 moderate, and 17–28 severe grading for neuropathies. 
Additionally, a more simplified scheme of the modified NDS that varies from zero (normal) 
to 10 (maximum deficit score) also indicates precisely a total loss of sensation to all 
sensory modalities and absent reflexes, as shown in Table 5 [32, 38]. 
 
Table 5 – Modified NDS [32]. 
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Reflex testing 
 
Traditionally, in neurology are tested all reflexes, while in the assessment of peripheral 
neuropathy is more frequent to test only the ankle reflexes. These are the most sensitive 
reflexes to early nerve injury, being usually reduced or absent. However, this method is a 
very poor predictor for ulceration [28, 31]. 
 
The examiner usually dorsiflexes the foot and softly strikes the Achilles tendon with a 
reflex hammer, repeating the procedure with reinforcement in case of reflex absence. 
Typically, the scores for the reflex testing are: 0 for absent, 1 for present but decreased, 2 
for normal, 3 for increased and 4 for increased with clonus [28, 33]. 
 
 
Superficial pain testing (Pinprick) 
 
Pain sensation can be efficiently tested with a sterilized safety pin. The site of testing is 
chosen according to a specific algorithm (or neuropathy score) [28]. Most commonly are 
tested the dorsum and the plantar aspect of the great toe of each foot, applying the 
stimulus (pinprick) once per feet and asking the patient to identify and describe the 
sensation, scoring precisely the obtained results. However, this screening method is highly 
subjective and thus, insufficiently reproducible. For this reason, must be used in 
combination with other measures [28, 33-34]. 
 
 
Vibration Testing 
 
Vibration threshold perception is another measure used for an accurate evaluation of 
nerve function. Usually, vibration sensation is measured with a 128-Hz tuning fork, or less 
frequently with 64- and 256-Hz tuning fork. This method relies especially on examiners 
experience, revealing a variable correlation with quantitative tests. Physicians must take 
into account factors like age and body surface area when identifying eventual nerve 
abnormalities [28, 39]. 
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Although this measure can be highly subjective in grading the neuropathy severity, the 
absence of vibration perception at the great toe is considerably correlated with 
development of foot ulcers [28, 33]. 
 
 
Temperature Perception 
 
This simple and inexpensive method requires minimal training and can be performed by 
nonmedical staff. Heat and/or cool sensation are generally measured with a tuning fork 
immerged in warm and/or icy water, respectively. This measure relies also on examiners 
experience and can be highly subjective, requiring additional procedures [28, 31]. 
 
 
Neuropathy Symptom Score (NSS) 
 
This score for defining and assessing symptoms was also developed by Dyck and his 
colleagues [40]. NSS includes proximal and distal symptoms of muscle weakness, sensory 
disturbances such as pain, numbness, unsteadiness in walking, and less frequently 
symptoms of autonomic neuropathy, such as impotence, orthostatic hypotension, 
nocturnal diarrhea [21, 32].  
 
Many patients report deep aching pain, a burning sensation, “knife-like”, sharp electrical 
“shock-like” pain, freezing, or a more continuous squeezing and hurting feeling (pressure 
myalgia). These symptoms are known as positive sensory symptoms because of evident 
“hyperactivity” of nerves and perceived as a presence of something that is usually absent 
[21, 32]. 
 
Negative sensory symptoms encompass “asleep”, “tingling”, “prickling”, “numbness,” 
“wooden, rubber, or dead feet” feeling and frequently used descriptors are “a wrapped 
feeling,” “retained sock feeling,” “cotton wool under soles,” and so on. Hyperalgesia and 
allodynia are also familiar neuropathic sensory symptoms and are defined as 
hypersensitivity to a normally mild painful stimulus and painful sensation induced by a 
normally non-painful stimulus, respectively [21, 32, 40].  
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In the greater part of diabetic patients both positive and negative sensory symptoms form 
a complex, acting simultaneously. Usually, these symptoms are identified by systematic 
questioning, as spontaneous reporting seems to point the positive symptoms [21, 32-34]. 
 
In most cases, composed neuropathic symptoms (painful and non-painful) are more 
accurate than single symptoms in diagnosing peripheral neuropathy. A total of 17 
symptoms are graded in the NSS (0 = absent and 1 = present) [40]. 
 
 
Toronto Clinical Neuropathy Scoring System 
 
This clinical scoring system comprises a number of simple screening tests that provide an 
accurate diagnosis of neuropathy in outpatient clinics. The Toronto group has validated 
this simplified scoring system (Table 6) against neurophysiological and pathological deficits 
obtained on sural nerve biopsy, concluding that it can be certainly used to document and 
monitor diabetic peripheral neuropathy [41, 42]. 
 
Table 6 - Toronto Clinical Neuropathy Scoring System [41, 42]. 
Symptom scores Reflex scores Sensory test scores 
Foot 
Pain 
Numbness 
Tingling 
Weakness 
Ataxia 
Upper-limb symptoms 
Knee reflexes 
Ankle reflexes 
Pinprick 
Temperature 
Light touch 
Vibration 
Position 
Symptom scores: present, 1; absent, 0. 
Reflex scores: absent, 2; reduced, 1; normal, 0. 
Sensory test score: abnormal, 1; normal, 0. 
Total score ranges between 0 and 19.  
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Diabetic patients are precisely questioned as to the presence or absence and specific 
characteristics of neuropathic symptoms in the feet and upper-limbs, and the presence or 
absence of unsteadiness when walking, as shown in Table 6 [41, 42]. 
 
This recent score highlights more the sensory symptoms and deficits as opposed to motor 
deficits. Sensory testing is usually performed on the first toe and graded as normal or 
abnormal while knee and ankle reflexes are graded as normal, reduced, or absent [41, 42]. 
 
 
Michigan Neuropathy Screening Instrument (MNSI) 
 
Several questionnaires can be helpful in screening patients for DPN. The MNSI is a 
combination of a symptom score (15-item questionnaire) and a physical examination 
score. The combination of these two scores results in valid and highly predictive value [43, 
44], justifying the choice for our study.  
 
The MNSI questionnaire can be used only as complementary method for the physical 
examination. Any methodology used for the identification, evaluation and documentation 
of neuropathic signs and deficits, must undoubtedly involve physical exam of the lower 
limbs, which remains the main aspect in the clinical diagnosis of DPN [44, 45] 
 
In our study, this brief questionnaire was used additionally as a simple screening tool for a 
more accurate diagnosis of diabetic peripheral neuropathy. All patients were asked to 
answer this questionnaire, allowing a more precise evaluation of the severity degree of 
diabetic neuropathy according to the MNSI, which has been developed specifically for 
distal diabetic polyneuropathy [44]. 
 
 
3.4.3 - Neurophysiologic examination 
 
Nerve conduction studies (NCS) and quantitative sensory testing (QST) are methods used 
in both routine clinical practice and in clinical trials for examining the peripheral nerve 
function.  
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Neurophysiologic assessment (used in our study to differentiate precisely patients 
according to their severity), mostly NCS and electromyography, are often used in 
suspected disorders of the peripheral nervous system. These unique techniques, with 
surface electrodes for nerve stimulation and evoked potential recording, can competently 
determine the impulse activity of the largest and fastest conducting sensory and motor 
myelinated nerve fibers [45]. 
 
 
Nerve conduction studies (NCS) 
 
NCS are electrophysiological studies, frequently used in clinical practice to assess and 
follow-up suspected DPN and other neuromuscular disorders. NCS are the most 
informative method of the neurophysiologic examination, and their inclusion certainly 
adds a higher level of specificity to the diagnosis [29]. For this reason, all controls and 
patients included in our study underwent electrophysiological assessment. 
 
In many cases, these studies are not required for the diagnosis of DPN. Most medical 
doctors reserve the use of this method to cases with symptomatic, confusing, unusual or 
severe neuropathy [29]. 
 
NCS can be requested in atypical cases of neuropathy in diabetic patients, which might 
suggest other forms of neuropathy. NCS can be also performed in rapidly progressing limb 
weakness, asymmetric/multifocal signs (suspected vasculitis), or a family history of 
neuropathy/feet deformities (suspected Charcot-Marie Tooth neuropathy) [14, 29].  
 
NCS are extremely valuable, as they are non-invasive, objective, and standardized, 
providing a highly sensitive measure of the functional status of sensory and motor nerves. 
Both afferent and efferent nerves can be tested; therefore, motor and sensory 
neuropathies can be accurately diagnosed [45-47]. 
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This method can determine precisely the distribution of abnormality (focal, multifocal, or 
diffuse) and whether the pathophysiology is mostly segmental demyelination or axonal 
degeneration [46, 47]. 
 
NCS results in reliable, reproducible, and form initial objective outcome measures in trials 
evaluating pharmaceutical treatment of DPN. Nevertheless, they must be performed in 
triplicate samples and by trained individuals [46-48]. 
 
This useful method consists from an action potential elicited by stimulating the nerve and 
conducted along a motor or sensory axon. In the normal healthy nerve, the electrical pulse 
propagates with a NCV of approximately 50–70 m/s. In our study, NCV propagated with 
50-55 m/s in healthy controls, whilst varied between 34 and 46 m/s in diabetic patients, 
according to their DPN status. The NCV value can be measured with great accuracy and 
objectively used to verify the presence, degree of severity, and level of peripheral nerve 
dysfunction [14, 48]. 
 
The results of NCS usually show amplitudes, distal latency of compound muscle action and 
sensory potentials, conduction velocity of fastest conducting fibers and minimal F-wave 
latencies. Hence, these studies are appropriate for longitudinal and population evaluations 
[28, 45]. 
 
The most important measured parameter remains the maximum nerve conduction 
velocity (NCV) for the segment of nerve between the stimulating and recording electrodes. 
The amplitude and configuration of the resulting signals are also essential, showing the 
combined motor action potential (CMAP) evoked from motor fibers and the sensory nerve 
action potential (SNAP) evoked from sensory fibers [45, 46]. 
 
The major factors that are considered to influence NCV are the integrity and degree of 
myelination of the largest fibers, the mean axonal cross-sectional diameter, the 
representative inter-nodal distance and the distribution of nodal ion channels [32, 49]. 
 
Large diameter axons loss is the principal structural deficit responsible, leading inevitably 
to a significant reduction of the sensory nerve action potential and compound motor 
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action potential. Demyelination produces a profound deficit in NCV and increases 
dispersion. However, it has been suggested to have only a minor influence in slowing of 
NCV in DPN [48, 49]. 
 
In some cases, NCS do not correlate well with symptoms and signs. Several 
electrodiagnostical abnormalities reproduce metabolic changes that are not associated 
with symptoms or some symptoms and signs are not clearly connected with 
electrophysiological variations [28, 45]. Moreover, Aδ- and C-fiber activities cannot be 
tested with this technique, neither with electromyography. Decreased NCVs or loss of 
CMAP or SNAP amplitudes, typical signs of peripheral nerve disease either focally or 
generally, occur mainly as a result of large fiber dysfunction [45]. 
 
Moreover, maximal NCV reflects many times incomplete features of neural activity of a 
small group of large diameter and heavily myelinated axons. This diagnostic method is also 
insensitive to early functional changes such as a decrease of Na+/K+ ATPase activity. 
Despite these obvious limitations, numerous consensus panels have highly recommended 
the addition of entire nerve electrophysiological testing (NCV, F-waves, sensory, and/or 
motor amplitudes) in multicentre clinical examinations of human DPN [32, 45]. 
 
 
Electromyography (EMG) 
 
EMG is the assessment of muscle activity, frequently used for testing the muscle and 
motor nerve fiber activities. Atypical EMG characteristics, such as acute or chronic 
denervation, can be attributed to a substantial loss of large motor nerve fibers, also focally 
or generally [45].  
 
When a patient with neuropathic pain reveals acute or chronic abnormalities, these can be 
used to support the clinical impression of injury to a specific peripheral nerve or to 
peripheral nerves in general as in a DPN, or even diabetic or alcoholic neuropathy. 
Nevertheless, DPN or focal nerve lesions with only small-fiber contribution can show 
normal NCVs and EMG values, despite considerable nerve damage and neuropathic pain 
[45-48]. 
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3.4.4 - Quantitative sensory testing (QST) 
 
QST is used with increasing frequency, particularly in clinical therapeutic trials, being one 
of the sensory measurement techniques necessary for neurological evaluation. This 
method can determine accurately absolute sensory thresholds for pain, touch, vibration, 
and hot and cold temperature sensations [28, 45]. 
 
QST aids in diagnoses by investigating and assessing the peripheral nerve function in 
specific fibers, such as large myelinated Aβ (vibration detection), small thinly myelinated 
Aδ (cold, cold-pain) and small unmyelinated C (heat, heat-pain) afferent nerve fibers. This 
extremely useful method is well accepted due its simplicity, non-invasiveness and non-
aversiveness. It allows a precise differentiation between peripheral neuropathy and 
mononeuropathy [28, 45]. 
 
QST systems usually measure the threshold of diverse stimuli related to different 
neuroanatomic pathways. Elevated sensory thresholds are associated with sensory loss, 
while lowered thresholds reveal allodynia and hyperalgesia [45].  
 
In a generalized peripheral neuropathy usually all QST thresholds show high values, 
suggesting that all fiber types are affected. When occurs dissociation, with normal 
vibration thresholds while other thresholds are abnormal, the presence of a small-fiber 
neuropathy is alleged. In asymptomatic patients, atypical thresholds are evidence of 
subclinical nerve damage [45]. 
 
There are typically two types of devices that are commercially available: those that 
produce specified vibration or thermal stimuli, and those that send electrical impulses at 
certain frequencies. These devices can vary from handheld simple tools to more expensive 
and sophisticated computerized equipment with complex testing algorithms, 
standardization of stimulation and recording measures, and comparisons to age- and 
gender-matched control values [28, 45]. 
 
Evaluation of Corneal Nerve Morphology for Detection and Follow-up of Diabetic Peripheral Neuropathy 
35 
 
Generally, the testing procedure encompasses two main methods for the threshold 
detection: the method of limits and the method of levels, both requiring cooperation from 
the patient. The method of limits implies a generation of increasingly and consecutively 
decreasingly strong stimuli, being the patient that indicates the first onset of sensation. 
With the second method, are tested specific levels with the patient reporting if the 
stimulus is identified [50]. 
 
In the method of limits, as already described, the subject is exposed to stimulus with 
changing intensity. The practical performance of this measurement is frequently 
influenced by a reaction time artifact which is almost irrelevant for fast conducted 
sensations, while for relatively slower conducted thermal sensations affects substantially 
the value of threshold. Reaction time artifact is more significant for warming than cooling, 
given that the primary afferent nerves are slower conducting. Its undesired effects can be 
simply reduced by using a slow rate of temperature variation [51]. 
 
In the method of levels a specific stimulus of preset intensity and duration is rapidly 
delivered to the subject, who subsequently describes the sensation. Although free from 
reaction time artifact, this estimating test lasts inevitably longer than the method of limits, 
by using series of constant stimuli [51]. 
 
The full duration of the method of levels is definitely determined by the device used to 
stimulate and obtain the subject’s response. In many cases, this method is considered to 
be more suitable than the method of limits, especially in the assessment of thermal 
perception thresholds in complex regional pain syndromes [51]. 
 
In summary, the method of limits proposes a short and quick test, with higher absolute 
thresholds and highly sensitive results, many times affected by artifacts. Whereas for the 
method of levels, this represents a longer test, providing accurate results, but with 
reduced sensitivity for disease detection or greater test–retest reproducibility [50, 51]. 
 
In both described methods the sensory stimulus is an objective physical event, while its 
response usually is a subjective description from a patient or control subject. If the 
reported value is abnormal, this represents an obvious but complex sign of nerve 
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dysfunction, being located anywhere along the sensory pathway between the receptor 
apparatus, the primary sensory cortex, and the association cortex [50, 51].  
 
Additionally, psychological factors play a significant role in sensory function perception. 
Consequently, QST differs from NCS in which the stimulus generates a precise evoked 
response that is generally more objective and independent of cooperation from the 
patient [50, 51]. 
 
 
3.4.5 - Other methods of assessment 
 
Sural nerve biopsy 
 
Nerve biopsy usually is a useful method in the diagnosis of inflammatory nerve 
complications such as vasculitis, sarcoidosis or infiltrative disorders such as tumor or 
amyloidosisis [14, 52].  
 
Sural nerve biopsy, has been used in the past years in the study of peripheral neuropathy, 
mostly when the etiology is undisclosed or in patients with diabetes with atypical 
neuropathies [52].  
 
However, this method is not normally accepted for the detection of DPN, because is an 
invasive procedure with well-identified consequences, which include persistent 
postoperative pain at the site of biopsy, sensory complications and deficits in the nerve 
distribution and allodynia, particularly in diabetic patient [53]. 
 
According to a report published by the American Academy of Neurology (AAN), the 
American Academy of Neuromuscular and Electrodiagnostical Medicine (AANEM), and the 
American Academy of Physical Medicine and Rehabilitation (AAPM&R), sural nerve biopsy 
is less suggested for the detection and the evaluation of peripheral neuropathy [14, 29]. 
 
This method can demonstrate the loss of myelinated and/or unmyelinated nerve fibers 
and segmental demyelination. It also reveals endoneurial microangiopathy characterized 
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by basement membrane thickening, pericyte degeneration, endothelial cell hyperplasia 
and luminal narrowing. However, these pathological modifications can be certainly shown 
with both clinical and neurophysiological examinations of peripheral neuropathy [14, 54]. 
 
Hence, there are no indications or recommendations regarding the use of sural nerve 
biopsy in the evaluation of DPN. This method has been more valuable for the detection of 
mononeuropathy multiplex or suspected vasculitic neuropathy [53, 54]. 
 
Furthermore, the need to repeat contra-lateral nerve biopsy and many other questions on 
the utility and reliability of this invasive method used to assess axo-glial dysfunction and 
axonal atrophy has led to serious doubts regarding its use as an end point in any future 
trials of human DPN [32]. 
 
 
 
Skin biopsy and quantification of intra-epidermal nerve fibers (IENF) 
 
Another less invasive and more sensitive method than sural nerve biopsy, which is well-
accepted in several clinical trials, is a 3-mm skin biopsy. Skin biopsy has been frequently 
used in the past years for investigating DPN, and has revealed to be a useful diagnostic 
tool in small fiber neuropathy. This technique allows a direct study of small nerve fibers, 
requiring several neuronal markers, such as neuron-specific enolase and somatostatin, or 
cytoplasmic axonal markers, used to immunostain skin nerves [29, 55]. 
 
Skin biopsy enables a detailed visualization and a reliable identification of early alterations 
in the most distal nerves, confirming many times the earliest damage. This method 
includes the use of formalin-fixed frozen sections for an accurate quantification of (IENF) 
density, as number/length of epidermis in patients with impaired glucose tolerance (IGT) 
and sensory neuropathy [55, 56].  
 
The quantification of IENF density is a sensitive evaluation for different body sites, age, 
and gender. Reduced IENF density has been detected in both type 1 and type 2 diabetes, 
as well as in IGT. In several studies were used skin biopsies at multiple sites, revealing a 
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diminution in IENF density from proximal to more distal sites. This fact suggests that small 
nerve fibers reduction occurs in a length-dependent way [57, 58]. 
 
Assessment of IENF density appears to be a reproducible and diagnostically sensitive 
method. This valuable technique can clearly show any loss of small-diameter nerve fibers 
in patients with complaints of burning pain in their feet, in cases when nerve conduction 
studies and clinical examination reveal normal results [57, 58]. 
 
In 2005, was published a guideline by the European Federation of Neurological Societies 
(EFNS). It describes the use of skin biopsy in DPN and includes recommendations on 
several methods for tissue processing and quantification of IENF, containing normative 
data and correlations with other clinical, electrophysiological, and morphologic tests. 
Moreover, the EFNS concluded that morphologic nerve fiber changes, such as axonal 
swellings, may reveal the progression of peripheral neuropathy, but additional studies are 
required to determine their diagnostic accuracy [59]. 
 
Recent studies have associated IENF density with other measures of DPN, showing a 
significant correlation between decreased nerve fiber lengths in the dermis and slowing of 
sural NCV. Additionally, IENF density in the distal leg has been revealed to correlate with 
heat and cold perception threshold, heat pain, touch and pressure sensation, and total 
neurological disability score (NDS). Hence, skin biopsy and IENF quantification could be 
used in many cases as a complementary method to confirm the obtained results [60-62]. 
 
 
Quantitative sudomotor axon reflex testing (QSART) 
 
In the past years, sophisticated methods, such as axon reflex, magnetic resonance imaging 
and corneal confocal microscopy were moderately used in clinical trials, and very often 
used in research environment [32].  
 
The quantitative axon reflex technique is chosen in cases when is necessary to evaluate 
the postganglionic axon function of the sudomotor system. The axon reflex can be 
Evaluation of Corneal Nerve Morphology for Detection and Follow-up of Diabetic Peripheral Neuropathy 
39 
 
obtained by stimulating the pain nerve fibers or through iontophoresis of acetylcholine, 
which controls and stimulates the release of nitric oxide through the axon reflex [63, 64]. 
 
This technique has demonstrated to be extremely sensitive in the detection and evaluation 
of DSPN, showing to be efficient in identifying early nerve injuries of neuropathy. Several 
recent studies have exposed that the neurovascular response mediated by the nerve axon 
reflex is lower in diabetic neuropathic patients. This less common method appears to 
correlate with different nerve function measurements, showing reasonable sensitivity and 
specificity in identifying and classifying patients with DPN [64, 65]. 
 
 
Magnetic Resonance Imaging (MRI) 
 
MRI has been used in some cases to demonstrate that subjects with DPN have a reduced 
cross-sectional spinal cord area than healthy controls in the cervical and thoracic regions. 
Nevertheless, progression or regression of this abnormality has not been assessed in 
possible studies. As a result, the possible use of this expensive and sophisticated method 
as an end point in clinical trials of human DPN remains to be confirmed by future works 
[32, 66]. 
 
 
Autonomic system testing 
 
Quantitative testing of ANS is a complex process and has represented during many years 
the main measurements of motor nerve function and sensory nerve function failure. 
Unfortunately, the indifference in the development of this type of measures was partly 
due to the incorrect but commonly shared opinion that autonomic neuropathy was merely 
a small and moderately obscure contributor to the peripheral neuropathies affecting 
patients with diabetes [25, 67]. 
 
In patients with diabetes, autonomic dysfunction can occur in two possible ways: as 
autonomic neuropathy accompanied by a structural injury of the peripheral nerve fiber 
and/or functional deficit without any identified structural lesion [67, 68]. 
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CHAPTER 4 – CORNEAL CONFOCAL MICROSCOPY 
 
  
4.1 - Introduction 
 
In the last thirty years various clinical techniques for assessing the living human cornea at 
the global and cellular level have progressed considerably, being frequently used to 
diagnose disease, disordered function or disability. These methods include specular 
microscopy, computerized corneal topography, high frequency ultrasound and in vivo 
corneal confocal microscopy (IVCCM) [4]. 
 
IVCCM imaging of the cornea has shown an exponential development over the last two 
decades. This technique emerged from the laboratory and it has progressively been used 
more in the clinical setting to evaluate inherited corneal diseases, corneal infections, 
contact lens wear and the effects of corneal surgery. This exponential progress has led to 
considerable improvement and enrichment of our knowledge of the human cornea in both 
its physiologically normal and pathological states. In the past years, numerous research 
studies have investigated the corneal nerves using IVCCM [69-71]. 
 
Modern IVCCM represents a non-invasive technique for obtaining high-resolution optical 
images from all corneal layers and membranes. This method is increasingly used for 
examining the living human cornea in normal healthy or pathological conditions, being an 
extremely useful clinical and research tool. The main characteristic of CCM is its ability to 
produce in-focus images of thick specimens, a process known as optical sectioning. High-
quality images are obtained point-by-point (in some cases, line-by-line) and then 
reconstructed [69, 70].  
 
IVCCM is also a fast technique, allowing “a prospective and reiterative assessment of the 
human cornea at high magnification” (Quoted from [70]). This sophisticated method can 
be unquestionably used to analyze the cellular constituents of the cornea, enabling the 
detection of slightest changes in characteristics of corneal nerves in DPN [71, 72]. 
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In brief, most recent research studies on corneal disorders and dysfunctions, induced by 
diabetes, used preferentially IVCCM. The main reason for using this technique is the fact 
that it allows sequential observations of the corneal sub-basal nerve plexus, giving 
information comparable or even superior to that obtained with histopathological 
examination. Furthermore, it provides detailed morphological characteristics of corneal 
nerves permitting quantification of corneal nerve morphology in normal and diabetic 
subjects [70-72]. 
 
 
4.2 - Principles of confocal microscopy 
 
The principle of confocal microscopy was originally invented Marvin Minsky in 1955, and 
patented in 1961. His first prototype, known as the “double focussing stage scanning 
microscope”, allowed examination of tissue specimens [4, 73]. 
 
CCM technique is based on an essential principle in its design, enabling optical sectioning 
of a quite thick, light scattering object, such as the human cornea. Its basic principle 
consists in the use of the same objective for two different roles in the process of acquiring 
a corneal image. For a better understanding of this concept, the principle of this technique 
is schematically illustrated in Figure 3 [4, 74]. 
 
 
Figure 3 - Illustration of the principle of confocal microscopy [74]. 
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The schematic representation of Figure 3 shows two separate objectives on each side of 
the thick specimen. The objective on the left side of the thick object is used for the 
illumination, while the other on the right side plays the role for collecting the scattered 
light and forming the image. In this scheme, a point source of light originated in the 
aperture S1 passes through the lens L1, which focuses this light onto a tiny spot in object, 
at the lens focal plane. The lens L2 is located in such a way that its focus is situated in the 
same focal plane as L1. Consequently, L2 yields an image of the small spot at the aperture 
S2 and all the light that passes through L2 is detected at S2 [74]. 
 
Unlike the schematic model, contemporary confocal microscopy systems use only one 
objective, which, similarly to the described scheme, illuminates a given point of the 
examined specimen, collecting afterwards the scattered light from the illuminated point. 
Light is passed through a tiny aperture and focused by an objective lens onto a small area 
of the specimen. The light is then scattered from the specimen, passing through the 
objective lens. This light is focused onto a second aperture which is set in a particular way 
that out of focus light is eliminated. The reflected light is detected by a photo-detector, 
like a photodiode, an avalanche photodiode or cameras based on a charge-coupled device 
(CCD camera) [4, 75].  
 
The ability of this system to discriminate the light coming from out of the focal plane 
generates images of higher lateral and axial resolution compared to conventional 
microscopy. The main limitation of this system is its small field of view. Nevertheless, it is 
possible to obtain a larger field of view by scanning the examined specimen. This can be 
done either by moving the specimen while the microscope remains still, or by moving the 
confocal system over a fixed specimen [4, 75]. 
 
Generally, IVCCM systems move over a stationary sample. The speed at which a single 
image of the field is obtained determines the microscope’s temporal resolution. High 
temporal resolution is extremely important and is undoubtedly preferred, given that poor 
resolution is frequently associated with amplified motion artifacts. These artifacts are 
originated by the involuntary movements of living human subjects during their 
examination. These unintentional and undesired movements are inevitably caused by 
pulse, respiration, and eye movement [4, 74-75]. 
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Another important feature that can seriously influence the acquired images is the spatial 
resolution. It is defined as the smallest distance between two separated points that can be 
identified and is usually quantified through the Rayleigh Criterion. Higher resolution, which 
corresponds to lower value of Rayleigh Criterion, is an important requirement for the 
examination of small corneal structures [74, 75].  
 
In CCM, two types of resolution are usually evaluated: axial and transverse resolution. 
Axial resolution, also known as depth, is the resolution in direction parallel to the light 
beam (smallest distance between two separate points along the light beam axis). High 
value of axial resolution in confocal microscopy can improve the image quality by about 
40%, when compared to other conventional techniques. Transverse resolution, also called 
lateral resolution, is the smallest distance between two different points in direction 
perpendicular to the light beam axis.  Transverse resolution depends on the xx and yy 
coordinates in the plane of a thick object, while axial resolution depends on the zz 
coordinate, orthogonal to the plane of the object [74, 75]. 
 
 
4.3 - Types of confocal microscopes 
 
During the last three decades, the original CCM has passed through numerous 
modifications and developments, resulting in different types of microscopy techniques and 
microscopes. The most important types are: Tandem Scanning Confocal Microscope 
(TSCM), Slit Scanning Confocal Microscope (SSCM) and Laser Scanning Confocal 
Microscope (LSCM). All three types are briefly described in the following paragraphs.  
 
 
4.3.1 - Tandem Scanning Confocal Microscope (TSCM) 
 
The TSCM comprises a rotating Nipkow disk with a high number of pinholes (for example, 
64.000) distributed in Archimedian spirals. Each pinhole has a corresponding conjugate 
pinhole diametrically opposite to it on the disk (Figure 4). The Nipkow disk spins extremely 
fast, depending on the microscope model (for example, 900 rotations per minute), with 
Evaluation of Corneal Nerve Morphology for Detection and Follow-up of Diabetic Peripheral Neuropathy 
44 
 
the illuminating light passing through numerous pinholes at the same time, and with the 
reflected light passing through the conjugate pinholes. This fast disk rotation allows a 
complete scanning of the entire specimen, in a time interval compatible with video signal 
requirements [76]. 
 
 
Figure 4 – Schematic illustration of the optical pathway used in TSCM [76]. 
 
 
TSCM is limited by the ratio of the holes to the disk area, which is very small 
(approximately 1-2%). Consequently, only a small part of the illumination light reaches the 
specimen, reducing also the fraction of scattered light. Decreased fraction of both 
illumination and scattered light results in a poor image quality and/or longer acquisition 
times for a given signal-to-noise ratio. Although less recommended for weakly reflecting 
specimens (such as human cornea), this scanning system was already used in several 
research works for studying and evaluating the human corneal morphology, mainly due to 
the real-time operation at high image acquisition rates [77]. 
 
 
4. 3. 2 - Slit Scanning Confocal Microscope (SSCM) 
 
The SSCM system is based on two adjustable and optically conjugate slits used for 
illumination and detection of reflected light. A fast moving two-sided mirror scans the 
complete image of a slit onto the microscope objective and de-scans the reflected light 
from the specimen. This principle is schematically represented in Figure 5 [74, 75]. 
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Figure 5 - Schematic diagram of the optical pathway used in the SSCM [74]. 
 
The scanning slit illumination can have several advantages when compared to spot 
illumination. Firstly, a great part of these devices have adjustable slits, permitting the 
variation in the thickness of the optical section and the fraction of light that reaches the 
specimen and the detector. Secondly, light throughput is considerably greater than that of 
the TSCM. Thirdly, numerous points are scanned in parallel, leading to a shorter scanning 
time [74, 75].  
 
These advantages enable the system to rapidly acquire high-quality images of transparent 
specimens. However, its main limitation is that this device can be considered truly confocal 
only in the axis perpendicular to the slit height. This results in low transverse and axial 
resolution [74, 75]. 
 
 
4. 3. 3 - Laser Scanning Confocal Microscope (LSCM) 
 
LSCM represents the latest technique of confocal microscopy. This system was used in 
most recent investigations, including our study on DPN. This sophisticated and expensive 
technique has become an extremely precious tool for a wide variety of research studies in 
the biological and medical fields for the imaging of thin optical sections in living and fixed 
specimens, varying in thickness up to 100 micrometers [78]. 
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This device uses coherent light emitted by a laser source and the beam is scanned over the 
back focal plane of the microscope by a set of galvanometer scanning mirrors. This 
microscopy system uses pinhole apertures. The emitted light passes through two different 
pinholes before reaching the photomultiplier detector. The first pinhole is positioned in a 
conjugate plane with the scanning point on the specimen. The second pinhole is located in 
front of the detector. The second pinhole plays the role of a “filter”, blocking the passage 
of out of focus light. The dichroic mirror has two main functions, reflecting the emitted 
laser beam onto the specimen, and allowing the passage of the reflected light onto the 
second pinhole aperture, as shown below in Figure 6 [74, 78]. 
 
 
 
Figure 6 - Schematic diagram of the optical pathway in LSCM [78]. 
 
 
4.4 - Clinical examination 
 
Currently, IVCCM devices involve contact with the cornea under local anesthesia. All 
available confocal microscopes used to examine the central region of the cornea require a 
coupling medium (gel) between eye and front surface of the lens, with the working 
distance dependent on the objective lens used [4]. 
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The front surface of the lens is moved forward gradually with a joystick until reaches the 
corneal apex, visualizing and allowing the identification of each of the five corneal basic 
layers. Thus, image acquisition starts when the objective lens is correctly aligned with the 
central cornea and properly positioned on the corneal surface, with eventual fine 
adjustments in the X-Y plane in order to improve the position. The obtained images are 
rapidly projected onto a highly sensitive camera, connected to sophisticated quantitative 
image analysis systems, and finally displayed on the monitor [4]. 
 
 
4.5 - Clinical applications 
 
As described previously, IVCCM allows ophthalmologists and researchers to detect and 
visualize living tissues at high resolutions. It can provide quantitative and qualitative 
morphological information, being often used for identifying and quantifying the 
pathological states of the corneal nerves and/or endothelial cell shape and density 
observations [74, 79].  
 
In the past years it was increasingly used in the detection and management of different 
pathological and infectious conditions. This technique has shown good results in the 
detection of corneal dystrophies and ecstasies, detection of infective keratitis, pre and 
post refractive surgery evaluation, monitoring of contact lens induced corneal 
modifications and also identification of corneal micro-deposits. In the last decade it was 
frequently used in the assessment of peripheral nerve damage and dysfunction in a wide 
range of different studies on DPN (described in details in Section II) [8, 69-79]. 
 
In the case of corneal dystrophies, the clinical diagnosis, assessment and differentiation 
were based mainly on slit-lamp bio-microscopy. However, this technique has limitations in 
providing morphological description at cellular level. The use of CCM technique allows 
researchers to visualize the slightest changes non-invasively and to clearly distinguish 
between different types of dystrophy in Bowman´s layer and the stroma, avoiding the use 
of invasive procedures such as biopsy with histopathological examination [79-81]. 
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CCM has proven to have a significant clinical relevance in the diagnosis of infective 
keratitis, being extremely useful in several studies that revealed different causes of this 
painful condition, which results in inflamed eye and impaired vision [79].  
 
In the case of refractive surgery, IVCCM has confirmed to be an invaluable tool, allowing 
the ophthalmologists to follow the corneal evolution after surgical intervention. This 
technique has been used for the quantitative and qualitative assessment of temporal 
modifications in keratocyte density, subepithelial deposits, stromal changes, and also 
nerve regeneration following photorefractive keratectomy (PRK) [79, 82-83]. 
 
CCM was frequently used in numerous research studies on corneal changes caused by 
contact-lens wear. This technique has shown to be very helpful in the detection of 
different types of stromal modifications, quantification of keratocytes loss and 
identification of inflammatory mediators release in the patients that use contact lenses.  
It has been also revealed that long-term contact lens wear may decrease the corneal 
sensitivity without necessarily affecting the distribution and morphology of corneal nerves, 
verifying the same with endothelial cells in diabetic contact lens wearers [79, 84-86]. 
 
As for the corneal microdot deposits, CCM has been intensively used to detect this 
condition usually caused by several pathological factors, such as Fabry´s disease, Wilson´s 
disease, hyperlipidemia, refractive surgery and also long-term contact lens wear [87-90]. 
 
Other clinical and research applications, regarding specially the study of corneal nerve 
morphology in diabetic patients, are described in the following section. 
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SECTION II 
 
STATE OF ART 
 
ASSESSMENT OF CORNEAL NERVE MORPHOLOGY WITH IVCCM 
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CHAPTER 5 – ASSESSMENT OF CORNEAL NERVE MORPHOLOGY WITH IVCCM  
 
In the last decade, several research groups have used IVCCM to study corneal nerve 
morphology and distribution in healthy and diabetic subjects. In this chapter are described 
the main aspects of different methods and objectives of most relevant and recent works in 
this area. All the papers here mentioned represent a field preparation for our own 
research work, given that in all these studies were defined, assessed and quantified 
corneal nerve morphologic alterations and dysfunctions by CCM. 
 
In a study on corneal structure and sensitivity, Rosenberg et al. [91], have used this non-
invasive diagnostic technique to show significantly reduced sub-basal nerve fiber bundles 
in insulin-dependent diabetic patients with DPN, compared to non-diabetic subjects. 
Reduced bundles and lower nerve ramification are associated with reduced corneal 
sensitivity in patients with severe degree of DPN. This study has also revealed considerably 
thinner epithelium in diabetic subjects with severe DPN compared to healthy subjects. 
 
In an improvement of the previous study, Malik et al. [92], have found considerably lower 
nerve fiber density, length as well as nerve branch density in diabetic patients (type 2) 
compared with controls. Other relevant aspect is that all mentioned measures are 
inversely correlated with the increasing severity of DPN. 
 
Later, Kallinikos et al. [93], have performed a different study in order to define possible 
alterations in the tortuosity (TC) of corneal nerve fibers in relation to age, duration of 
diabetes (type 2), glycemic control, and neuropathic severity. They concluded that IVCCM 
is an appropriate technique that enables a rapid and non-invasive in vivo evaluation of 
corneal nerve tortuosity. They found that an increased tortuosity is a morphologic 
abnormality associated to the degree of severity of somatic neuropathy, reflecting changes 
in the nerve degeneration and regeneration in diabetic patients.  
 
Confocal Laser Scanning Microscopy (CLSM) was used in a research study performed on 
the epithelial nerve structure in the human cornea (Stachs et al. [94],). The main objective 
was to visualize the spatial arrangement of the epithelium, nerves and keratocytes.  
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The obtained corneal images reconstructed three-dimensionally have revealed that thin 
nerves run in the subepithelial plexus aligned parallel to Bowman’s layer, being partially 
interconnected. CCM allowed an accurate quantification of the diameter of main corneal 
nerve fibers [94]. 
 
Parwez et al. [70] used IVCCM to detect and assess changes in the corneal architecture in 
diabetic patients (type 2) that suffer from DPN. They have confirmed that nerve fiber 
density (NFD) and length (NFL) in diabetic subjects are significantly affected, showing also 
that these morphometric parameters are inversely correlated with increasing degree of 
severity (mild, moderate or severe) of DPN compared with healthy controls. 
 
A useful study based on IVCCM and microstructural analysis, performed by Grupcheva et 
al. [95], has identified changes in corneal nerve density and morphology, with a precise 
quantification of number and diameter of the nerve beadings. Furthermore, it was 
established a correlation between the identified changes and subjects age. 
 
In a posterior study, Mocan et al. [96], have studied the morphologic alterations in both 
corneal stromal and sub-basal nerves in diabetic patients (type 2). They revealed that sub-
basal nerve length and total nerve branching are significantly lower in diabetic patients 
compared to controls. It was shown also that stromal nerve thickness as well as sub-basal 
nerve plexus thickness and tortuosity are significantly higher in diabetics. 
 
In 2007, Quattrini et al. [97], have performed a valuable study on small fiber damage in 
human diabetic neuropathy. They have quantified small nerve fiber pathological changes 
in diabetic patients using the IVCCM technique, complementing the obtained results with 
the IENF assessment. In their study, all diabetic patients selected for neuropathy 
classification underwent neurological examination, neurophysiological evaluation, 
quantitative sensory testing (QST), skin biopsy for IENF quantification and CCM in order to 
identify and quantify corneal nerve fibers. It was found that IENF density, corneal nerve 
fiber density (NFD), branch density (NBD) and length (NBL) were progressively reduced in 
diabetic patients, according to their severity degree of neuropathy. This research group 
concluded that IVCCM technique can accurately identify and quantify small nerve 
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damages, detecting early stages of corneal nerve damage and recommended this 
technique for the diagnose and assessment  of human DPN. 
 
Later, was performed an interesting study on the diagnosis of neuropathy in patients with 
Fabry disease (Tavakoli et al. [98],). This research group has also used CCM to quantify 
small-fiber pathology, complementing with non-contact corneal aesthesiometry (NCCA) to 
quantify loss of corneal sensation, together with other established tests of neuropathy, 
such as detailed quantification of neuropathic symptoms, neurological deficits, 
neurophysiology and quantitative sensory testing (QST). Its results have clearly shown that 
all patients with Fabry disease had significant neuropathic symptoms. According to CCM 
quantification, corneal nerve fiber (NFD) and branch densities (NBD) were significantly 
reduced in both female and male patients when compared with control subjects. 
Moreover, the severity degree of neuropathic symptoms, as well as the neurological 
component of the Mainz Severity Score Index correlated significantly with the obtained 
results with QST and CCM. The authors indicated that both CCM and NCCA techniques 
provide accurate information, to detect and quantify early nerve fiber damage and 
dysfunction, respectively, in patients with Fabry disease. 
 
In the article published by Lalive et al. [99], the corneal stromal nerve alterations imaged 
by laser scanning in vivo confocal microscopy (LSCM), in a patient with peripheral 
autoimmune neuropathy, were well described. This group has clearly shown that the 
application of this technology is appropriate for following the nerve damage progression, 
as well for assessing the responses to treatment. The authors have suggested that LSCM 
may be a valuable tool in the early detection of DPN. 
 
Other recent study, performed by Visser et al. [100], has described an analogous 
population of thin and tortuous corneal nerves with a beaded form in healthy subjects, 
confirming and complementing the data described by Lalive et al. [99] They stated that an 
accurate distinction between the nerves in cases with and without peripheral neuropathy 
could be made through the difference in nerve diameter. 
 
A latest study on automatic analysis of DPN, published in 2011 by Dabbah et al. [8], has 
also shown the importance and utility of CCM for the analysis of corneal nerve 
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morphology. The authors of this research work have published various articles in the past 
years. In this interesting article, they mentioned that existing methods are in many cases 
insufficient, with poor sensitivity and requiring expert assessment.  Most of recent 
diagnose and follow-up techniques focus only on large fibers (neurophysiology) or are 
invasive (skin/nerve biopsy). 
 
Inspired by other recent studies (Malik et al., [92]; Kallinikos et al., [93]; Parwez et al., 
[70]), and confirming with their own results, Dabbah et al. [8] have described several 
advantages of CCM technique, pointing out that this non-invasive and reiterative method 
might be an ideal surrogate for early diagnosis and an early biomarker for human DPN. 
CCM could identify the patients at risk, requiring if necessary a quick and more intense 
intervention including improved glycemic, blood pressure and lipid control. In addition, the 
authors mentioned that a sensitive surrogate endpoint would considerably reduce the 
difficulties of the development of disease-modifying therapeutics by improving the ability 
to test therapeutic efficacy. 
 
The system for automated analysis of CCM images presented in their paper uses the dual-
model property in a multi-scale framework, in order to generate feature vectors from 
localized data at each pixel [8]. As in other prior similar studies, corneal nerve fibers in 
CCM images are shown as bright linear structures that follow a principal direction. 
However, these fibers appear to have their own independent local orientation, different 
dimensions of length and diameter. According to the authors, longer nerve fibers with 
larger diameter are considered to be the primary trunks, while smaller nerve fibers 
emerging from these main trunks are called secondary nerve fibers (or nerve branches) 
[8].  
 
Dabbah et al. [8], also revealed promising results in distinguishing control and patient 
groups using features such as nerve fiber length (NFL), nerve fiber density (NFD), nerve 
branch density (NBD) and tortuosity (TC) of nerve fibers. Once more, the authors have 
confirmed that abnormal subjects usually have less nerve fibers and more tortuous 
structures than healthy normal subjects. They concluded that the multi-scale dual-model 
method can be successfully used to detect corneal nerve fibers in CCM images. 
Furthermore, in their evaluation the proposed method outperformed other previous 
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methods and obtained the lowest error, achieving this performance with reduced training. 
The authors suggested that the simplicity of the developed method might be a potentially 
important matter in the practical implementation in the clinical field. 
 
The authors mentioned that the clinical utility of the dual-model method was also 
evaluated by comparing the automatic detection and classification against expert manual 
delineation of the images. The obtained results have shown encouraging clinical 
performance for the stratification of neuropathic severity. According to them, the 
automated analysis produces equivalent results to manual analysis, while being a faster 
and potentially more reliable and practical choice due to its stability and immunity to 
inter/intra-observer variability. The authors have used for the comparison and assessment 
of the correspondence between manual and automatic detection of results, the NDS 
score, which is, in their opinion, adequate for establishing the clinical severity of 
neuropathy, but not enough for a more detailed assessment of clinical utility because it 
does not detect small fiber damage. For this reason, CCM was clearly recommended by the 
authors, as it can evaluate small fiber damage, a performance that can only be achieved by 
either nerve or skin biopsy, both of which are invasive and require an intensive labor 
assessment [8].  
 
A most recent study on detection of diabetic sensorimotor polyneuropathy (DSP), 
published in 2012 by Ahmed et al. [101], aimed to identify the concurrent and predictive 
validity of CCM parameters in the cross-sectional identification of DSP and in the 
prediction of future DSP in longitudinal analysis, intending to determine in CCM images the 
finest parameter that best identifies this pathological condition in type 1 diabetes and also 
to describe its performance features. The authors intended to include type 1 diabetic 
subjects with a wide range of nerve injury, varying between absent and detectable nerve 
damage to severe DSP. This was possible by using the Toronto Clinical Neuropathy Score 
(TCNS, previously described with more detail), an validated grading system score to 
evaluate history and physical exam components that allowed to stratify the number of 
subjects according to their severity degree (absent, mild, moderate, and severe) of 
diabetic polyneuropathy at the time of study [101]. 
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Similarly to some previous studies, all patients underwent examination in both eyes of 
corneal nerve fibers in the Bowman layer of the cornea. The mean of the two obtained 
images from contralateral eyes was calculated to determine the mean values of CCM 
parameters, such as NFL, NFD, NBD, and TC, all measured with analytical software. DSP 
was diagnosed using well-known clinical and electrophysiological criteria (published by the 
American Academy of Neurology, the American Association of Electrodiagnostic Medicine, 
and the American Academy of Physical Medicine and Rehabilitation, Neurology in 2005). 
The authors were based on this consensus, defining electrophysiological abnormality 
according to the presence as a minimum of one abnormal nerve conduction parameter in 
both dominant-side sural and peroneal nerve distributions. They found that DSP was 
present in 37% subjects, showing that CCM parameters were significantly lower in these 
subjects, with the exception of tortuosity. They concluded that among identified CCM 
parameters, NFL best differentiated DSP cases from control/healthy subjects [101]. 
 
Labbé et al. [102], have presented a study focused on the sub-basal nerve morphology, 
aiming to evaluate the relationship between the in vivo confocal microscopic (IVCM) 
morphology of sub-basal corneal nerves and corneal sensitivity in patients treated for 
glaucoma. In this study, the authors performed unilateral IVCM (i. e., only one eye of each 
subject was included) in all patients, assessing the corneal nerve fibers in the Bowman 
layer of the cornea. The authors analyzed the following nerve parameters: density (NFD), 
width (NFW), number of nerve beadings (NNB), branching density (NBD), tortuosity (TC) 
and reflectivity (RC). The obtained results have revealed a significantly decreased corneal 
sensitivity in glaucoma and dry eye patients compared to normal control subjects [102].  
 
The density and number of sub basal corneal nerves were also significantly reduced in 
glaucoma and dry eye patients compared to healthy controls. However, there were no 
significant differences in terms of sub basal nerve width, number of beadings, tortuosity, 
reflectivity and number of branching between the glaucoma, the dry eye and the control 
groups [102]. 
 
Other recent study, also published in 2012, by Edwards et al. [103], was focused on the 
diagnosis and monitoring of DPN and shown promising results. The authors, as in many 
previous studies, used IVCCM to measure morphologic parameters of sub-basal corneal 
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nerves. The patients with diabetes that were involved  were with predominantly mild or 
no neuropathy. All individuals (patients and healthy controls) underwent evaluation of 
diabetic neuropathy symptom score (NSS), neuropathy disability score (NDS), testing with 
10g monofilament, quantitative sensory testing (QST) (warm, cold, vibration detection) 
and nerve conduction studies (NCS). 
 
Edwards et al. [103], analyzed the following corneal morphologic parameters: NFL, NBD 
and TC, determining differences between subjects with and without DPN and healthy 
controls and using correlations between the measured parameters and traditional tests of 
DPN. They found that the NFL was significantly reduced in diabetic individuals with mild 
DPN compared to both controls and diabetic individuals without DPN. NBD was 
significantly decreased in individuals with mild DPN compared to controls. NFL and NBD 
revealed weak correlations to most measures of neuropathy, with the strongest 
correlations to NCS parameters. Regarding the corneal nerve fiber tortuosity (TC), the 
authors did not quantified significant differences, showing only a frail correlation to the 
vibration detection threshold. The authors have recommended CCM for the assessment of 
corneal nerve morphology, clearly calling attention to the fact that is a non-invasive and 
fast technique capable of showing noticeable differences between persons with and 
without DPN [103]. 
In vivo corneal confocal microscopy (IVCCM) was employed in a study (published by Nitoda 
et al.,[104]) with a different approach. The authors intended to assess the variety of 
corneal nerve fiber alterations between diabetic patients (type 2), categorized into three 
different groups according to retinopathy status, and non-diabetic patients. In this work, 
CCM images of the sub-basal nerve plexus of the diabetic and healthy participants were 
collected. The chosen parameters for analysis were: corneal nerve fiber density (NFD), 
nerve branch density (NBD), nerve fiber length (NFL), and nerve fiber tortuosity (TC). 
Diabetic patients were stratified into three groups according to the classification of 
diabetic retinopathy severity degree, based on indirect fundoscopy, fundus photography, 
and fluorescein angiography findings. Additionally, a separate classification into four 
distinct groups according to the severity of DPN was also used, based on the results of 
clinical and electro-diagnostic examinations [104]. 
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The results obtained confirmed prior results, showing that average values of NFD, NBD, 
and NFL are lower, differing significantly according to DR status and DPN severity, whereas 
TC was found to be higher in diabetic patients than healthy control subjects. The authors 
have found a positive correlation between corneal and peripheral nerve damage in 
diabetics. Moreover, nerve fiber damage of the sub-basal nerve plexus of diabetic corneas 
was found to progress jointly with DR and DPN. Once more, CCM method was clearly 
recommended as a promising adjuvant technique for the early diagnosis and assessment 
of human DPN [104]. 
Other relevant study on retinopathy complications was performed by Popper et al. [105], 
at the IBILI Center of Ophthalmology, in partnership with Departments of Instrumentation, 
IBILI and Physics Department of University of Coimbra. The research group involved 
members that are currently involved in NeuroCornea Project, A. M. Morgado and M. J. 
Quadrado. The study employed confocal imaging to evaluate in vivo changes in density 
and morphology of subbasal nerves (SBN) and highly reflective cells (HRC) in corneas of 
diabetic patients with mild and moderate diabetic retinopathy. The authors affirmed that 
basal cell density in diabetics was significantly decreased, fact that may explain the 
neurotrophic state and poor epithelial healing, characteristic for diabetics. Furthermore, 
the authors observed that the number of very HRC beneath the basal epithelial cells’ layer 
was significantly higher in diabetics than healthy controls. They concluded that the 
decrease in the number of SBN and of basal epithelial cells in the corneas of diabetic 
patients characterizes the retinopathy condition and these changes might be related to 
each other. 
 
Resuming the information described in all studies mentioned in this chapter, many 
research groups obtained good results. Most of them focused principally on three 
essential parameters: nerve fiber density (NFD), nerve fiber length (NFL) and nerve 
branching density (NBD). These studies revealed that all three parameters are significantly 
lower in diabetic patients compared with controls. Furthermore, some studies have shown 
also that these morphometric parameters are inversely correlated with increasing degree 
of severity (mild, moderate or severe) of DPN compared with healthy controls. 
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Other groups evaluated in their studies parameters like nerve fiber width (NFW) and 
tortuosity (TC), proving that these parameters were significantly higher in diabetics 
patients compared with healthy controls. 
 
At last, some research groups complemented the existing data with information on 
additional parameters, such as nerve branching density (NBD), nerve branching pattern 
and branching degree, as well as number of nerve beadings (successive changes in nerve 
fiber caliber, calculated as the number of well-defined hyper-reflective points per unit of 
length), showing that it is possible to identify major changes between control and diabetic 
patients, and within diabetic groups, according to the severity degree of DPN. 
 
However, a substantial part of these results are partially inconclusive, requiring for 
additional study and improvement to identify and quantify with more accuracy the 
differences between the corneal nerve morphology of diabetics (with and without DPN) 
and control groups.  
 
Our study aims principally to complement and at the same time to confirm with our own 
findings the existing data on the following parameters: NFD, NFL, NFW, TC, NBD, NBP and 
NBA. All parameters were assessed in individuals divided in control groups, and diabetic 
groups, according to the severity degree of DPN.  
 
The selection of these parameters is entirely justified by the published results of all 
described studies. The exact methodology of our study is described in the following 
section, explaining in detail different steps of our study, including patients’ selection and 
classification, image acquisition and selection, electrophysiological measurements, as well 
as the algorithm and automatic image processing description. 
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CHAPTER 6 – RESEARCH DESIGN, AIMS AND METHODS 
 
6.1 – Key steps of study 
In numerous studies described in previous chapters, it was clearly accentuated that an 
accurate and earlier diagnosis, as well as follow-up of DPN has a supreme importance for 
establishing proper prevention methods or treatment. However, the earlier diagnosis 
continues to be a true challenge.  
The main goal of NeuroCornea project is the development of an automatic segmentation 
method for extracting corneal nerve morphologic characteristics for the early diagnosis 
and follow-up of DPN. The automated algorithm should be able to identify and perform a 
detailed analysis of several morphometric parameters from corneal sub-basal nerve 
plexus. This project is also focused on the development of an optical confocal module, 
designed to be included in standard slit-lamp equipment for corneal imaging.  
The main objectives of my work are to identify and assess the concurrent and predictive 
validity of CCM morphologic parameters in the case-control identification and 
classification of DPN. The evaluation of the morphology of the corneal nerves is a well-
structured process that involved different steps in order to achieve its purpose. The key 
steps are precisely described as follows: 
 To obtain CCM images from randomly selected diabetic type 2 patients and 
healthy controls, in order to evaluate the distribution and morphology of corneal 
nerves (random selection was performed to reduce bias);  
 To define and quantify alterations in the morphologic characteristics of sub-basal 
corneal nerve fibers in diabetic patients affected by DPN, according to the severity 
degree categorization; 
 To assist the development and improvement of an automatic algorithm for the 
identification, extraction and quantification of several morphometric parameters 
of corneal nerves, evaluating it against manual segmentation of the corneal nerves 
by an experienced examiner;  
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 To compare and correlate the obtained results with traditional neurological and 
electrophysiological tests used for the screening and assessment of DPN; 
 To identify the most relevant morphometric parameters and to evaluate their 
suitability for the early detection and follow-up of DPN with CCM.  
 
6.2 – Team and institutions involved in NeuroCornea project 
Our project is a joint effort by IBILI - Institute of Biomedical Research on Light and Image, 
from the Faculty of Medicine, University of Coimbra; the Instrumentation Center, from the 
Physics Department of the Faculty of Science and Technology, University of Coimbra; and 
the Departments of Ophthalmology, Endocrinology and Neurology, from Coimbra 
University Hospitals.  
The team consists of researchers with expertise on optical and electronic instrumentation, 
medical image processing and experienced medical doctors (ophthalmologists, 
endocrinologists and a neurophysiologist). Currently, more students are involved in the 
project, with their thesis based on works that cover different aspects of the project.  
 
6.3 – Classification of DPN case and control individuals 
In our study were included 12 randomly selected diabetic patients (type 2, insulin-treated, 
with mean age of 58±10 years), followed at the Department of Endocrinology of the 
Coimbra University Hospitals, and 8 age-matched non-diabetic control individuals (with 
mean age of 54±7 years).  
Initially, we intended to classify all selected diabetic patients in 4 groups, according to the 
degree of severity of neuropathy (absent, mild, moderate and severe) by physical 
examination, consisting in a complete evaluation of reflex and sensory deficits, according 
to Michigan Neuropathy Screening Instrument (MNSI) [106]. 
The obtained classification (shown in Figure 7) was slightly different of the expected one, 
with diabetics divided in the following 3 main groups: absent (4 patients, 53±11 years), 
mild (5 patients, 58±9 years) and moderate DPN (3 patients, 60±9 years), without any 
patient with severe degree. 
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Physical assessment was conducted according to guidelines of the Declaration of Helsinki 
and submitted to approval by the Medical Ethics Committee of the Faculty of Medicine, 
Coimbra University. All clinical examinations were performed according to the 
International Guidelines for Diagnosis and Management of DPN (presented in Table 4, 
Chapter 3.4.1), and according to MNSI (Figure 8), comprising feet appearance evaluation, 
ulceration, ankle reflex testing and sensory deficit evaluation (superficial pain evaluation, 
light touch perception, and vibrating sensation) graded according to the severity level that 
is associated to impaired sensation.  
 
 
Figure 7 – a) Pie-chart representing the individuals involved in the study, divided in four groups: 
control; diabetics without DPN, with mild DPN and with moderate DPN; b) Scatter chart 
representing the mean age values ± standard deviations, corresponding to the four groups. 
a b 
Figure 8 – MNSI: Physical assessment (University of 
Michigan, 2000), [106] 
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For a more complete evaluation, we used additionally a brief 15-item questionnaire 
(Figure 9) as a complementary screening tool for a more precise diagnosis of DPN. All 
patients were kindly asked to answer this questionnaire, allowing a more accurate 
evaluation of the severity degree of diabetic neuropathy according to the MNSI, which has 
been developed particularly for distal diabetic polyneuropathy [106].  
Each physical examination and questionnaire evaluation was performed by experienced 
medical doctors at the Department of Endocrinology of the Coimbra University Hospital, in 
a random testing order, without previous information of other test results to reduce bias.  
Furthermore, we verified the entire clinical history of each diabetic patient to ensure that 
peripheral neuropathy is a consequence only of diabetes, excluding other rare possible 
causes that are described in next section. 
 
 
 
 
Figure 9 – MNSI Questionnaire (University of Michigan, 2000), [106] 
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6.4 – Diabetic patients: exclusion of other causes for neuropathy 
As mentioned before, in patients, to ensure that peripheral neuropathy is a resulting 
condition only of diabetes, we have checked the complete clinical history of each patient, 
in order to exclude other potential causes.  
We have thoroughly verified the existence of several different abnormalities implicated in 
the pathogenesis of this nerve disorder, such as alcohol related neuropathy, frequently 
associated to nutritional neuropathy (vitamins B1, B3, B6 and especially B12 deficiency), 
uremic neuropathy (uremic toxins), hypothyroidism (uncommon cause, can lead to carpal 
tunnel syndrome), cancer-related neuropathy, inflammatory, as well as neuropathy caused 
by pernicious anemia (associated to gastritis), porphyria, and neuropathy caused by 
specific medications. For a better understanding, all these conditions are described in the 
following sub-sections.  
 
6.4.1 – Alcohol related neuropathy 
Alcoholic neuropathy is a complex condition and most likely due to several factors that are 
associated to nutrition disorders and alcoholism. The toxicity of alcohol can result in direct 
poisoning of the nerve fibers, or in indirect consequences, such as poor nutritional status 
and vitamin deficiencies. The indirect consequences are in many cases difficult to 
determine, given the existing limitations in assessing efficiently nutritional deficiencies 
versus alcohol toxicity [107]. 
 
6.4.2 – Nutritional neuropathy 
Neuropathies related to nutritional and vitamin deficiencies are frequently associated to 
extended parenteral nutrition, nutrition disorders (poor quality or/and insufficient 
quantity), alcohol abuse, physiological states (such as pregnancy), and certain medications 
(such as isoniazid or penicillamine that are pyridoxine antagonists), which may also result 
in a deficiency condition [107]. 
Evidence supporting a worse nutritional condition related to alcohol toxicity is the 
discovery that alcohol reduces vitamin B1 (thiamine) absorption in the intestine and 
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decreases hepatic thiamine storage. Consequently, a diminished phosphorylation of 
thiamine leads to a decrease of the active form of thiamine [107, 108]. 
There are many conditions associated with a diminished ability to an impaired absorption. 
These conditions comprise autoimmune diseases, pancreatic diseases, pernicious or 
unexplained anemia, ileal resection, Crohn's disease, HIV infection, gastritis, gastric or 
small intestine surgical interventions, malabsorption syndromes, multiple sclerosis, and 
the use of histamine receptor antagonists or proton pump inhibitors [109, 110]. 
Vitamin B6 (pyridoxine) deficiency in most cases occurs in the circumstances of general 
malnutrition, related with cases of alcoholism, or with medications such as isoniazid 
hydralazine, which are pyridoxine antagonists.  Some studies have revealed cases of 
neuropathy related to pyridoxine [107, 108]. 
Vitamin B12 (cobalamin) is an important dietary nutrient; therefore its deficiency can cause 
a number of serious undesired conditions including peripheral neuropathy. Vitamin B12 
insufficiency can cause megaloblastic anemia (although not always present in those with 
prominent neurological manifestations), nerve fiber damage and degeneration of the 
spinal cord. It is frequent for anemia to develop first, but this is not always the case [107-
109].  
 
6.4.3 – Neuropathy caused by pernicious anemia/gastritis 
Neuropathies can be associated in some cases to pernicious anemia (PA), the most 
frequent cause of vitamin B12 deficiency. PA represents a relevant condition only when 
associated with chronic atrophic gastritis, which is recognized mainly by the loss of gastric 
mucosal folds and thinning of the gastric mucosa. There are two major types of chronic 
gastritis (based on whether the lesion affects the antrum, region that contains gastrin 
secreting G-cells):  type A (autoimmune) and type B (non-autoimmune) [111-113]. 
PA may be related with several other autoimmune endocrinopathies, such as Hashimoto’s 
thyroiditis, Addison’s disease, gonadal failure, hypoparathyroidism, Graves’ disease, 
vitiligo, myasthenia gravis, the Eaton-Lambert syndrome, etc. [111-113]. 
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PA typical symptoms consist of fatigue, weakness, faintness, vertigo, tinnitus, palpitations, 
angina, and reduced exercise capacity with pallor, slight icterus, tachycardia, and systolic 
flow murmur on exam [111-113]. 
PA associated with chronic gastritis lead to B12 deficiency, which usually results in 
gastrointestinal complications, such atrophic glossitis, megaloblastosis, diarrhea, 
malabsorption and gastric adenocarcinoma [111-113]. 
Most frequent neurologic complications include peripheral neuropathy, often diagnosed 
by numbness and paresthesias, specific lesions of the dorsal and lateral columns (with 
typical symptoms, such as limb weakness, spasticity, and extensor plantar reflexes), typical 
lesions of the spinal cord (mainly sub-acute axonal and myelin degeneration) and 
cerebrum (with changes varying from mild personality defects, moderated memory loss to 
obvious psychosis (also called megaloblastic madness) [111-113]. 
 
6.4.4 – Uremic neuropathy 
Other type of neuropathy that we aimed to exclude is the uremic neuropathy, a less 
common type caused by uremic toxins. The severity degree of this neuropathy is strongly 
correlated with the severity of the renal insufficiency. Uremic neuropathy, in some cases 
associated to mononeuropathy, is considered a dying-back neuropathy (distal axonopathy) 
or central-peripheral axonopathy mostly with consequences of secondary demyelination 
[114, 115]. 
The pathophysiologic mechanism of uremic neuropathy continues unclear. Fraser et al., 
[116] suggested that neurotoxic compounds diminish energy supplies in the axon by 
inhibiting nerve fiber enzymes that are essential for the maintenance of energy 
production. Even though all neuronal perikarya would be affected likewise by the toxic 
assault, the long axons would be the most affected, degenerating earlier since the longer 
the axon, the larger the metabolic load that the perikaryon would tolerate. In toxic 
neuropathy, dying back of axons is more accentuated in the distal aspect of the neuron 
and may be caused by a metabolic failure of the perikaryon [114-116]. 
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Regarding the pathophysiology of uremic neuropathy, it has been postulated in some 
publications that peripheral nerve damage could be also related to an interference with 
the nerve axon membrane normal function and inhibition of Na+/K+ -activated ATPase by 
toxic factors in uremic serum [116]. 
Bolton et al. [117] theorized that membrane dysfunction was occurring at the 
perineurium, which plays important role as diffusion barrier between interstitial fluid and 
nerve, or within the endoneurium, which acted as a barrier between blood and nerve. 
Consequently, uremic toxins may enter the endoneural space at either site and generate 
direct nerve damage, with water and electrolyte shifts causing increase or decrease of the 
space. 
 
6.4.5 – Hypothyroidism related neuropathy 
Hypothyroidism is a clinical condition mainly characterized by deficient levels of thyroid 
hormones (particularly TT3 and TT4) with raised TSH. Peripheral neuropathy may be 
associated with hypothyroidism, which typically develops dangerously over a long period 
of time principally due to irregular drug administration and ineffective replacement of 
thyroid hormone [118].  
Several medical sources affirm that neurological symptoms are infrequent in thyroid 
disease patients with hypothyroidism. However, in the past years, numerous thyroid 
patients have complained of neurological type symptoms. Many of these patients endure 
with great effort these symptoms despite the fact that they are suitably treated to correct 
their thyroid hormone disproportion [119, 120]. 
 
6.4.6 – Cancer-related neuropathy 
One of the most frequent neurologic consequences of cancer is peripheral neuropathy, 
which can be caused directly by nerve injuries resulting from surgery; damage to nerves 
from compression or infiltration by tumor tissue; injuries resulting from nerve infections 
(such as shingles); neurotoxicity of cancer treatment (radiation treatment - depending on 
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the radiation dose tuning, or chemotherapy – depending on total dose received over 
time); metabolic derangements; and paraneoplastic disorders [121, 122].   
In the case of paraneoplastic disorders, any part of the central or peripheral nervous 
systems can be injured. Paraneoplastic neuropathies can lead in many cases cause to 
severe and permanent neurologic morbidity [121, 122].   
 
6.4.7 – Neuropathy caused by porphyria 
Porphyria represents a group of rare metabolic disorders, which are principally 
characterized by enzymatic deficiencies or failing in the biosynthesis of an element called 
heme, a metalloporphyrin that is the main result of porphyrin metabolism. There are 
several distinct forms of porphyria, classified according to the tissues that remain 
preferentially affected or where the metabolic disorder occurs (acute hepatic porphyrias, 
acute intermittent porphyria (AIP), hereditary coproporphyria, variegate porphyria, or 
erythropoietic porphyrias) [123-125]. 
Porphyric neuropathy usually appears in association with other characteristics of different 
types of porhyria. In case of acute hepatic porphyria, neuropathy occurs with abdominal 
pain, distorted mental status changes and autonomic dysfunction. Weakness is a common 
feature for the patients with acute intermittent or hereditary porphyrias, with particular 
vulnerability of motor nerve fibers, principally the radial and peroneal nerves. Subclinical 
neuropathy (characterized by reduced motor and sensory conduction velocities) has also 
been reported in a small number of patients with latent AIP, which have not revealed any 
neurologic deficit at the time of examination [124-126]. 
 
6.4.8 – Inflammatory neuropathy  
Inflammatory neuropathies are in most cases disorders of peripheral nerves and 
occasionally of the central nervous system. This type can affect individuals at any age, 
being related to a single or many of a large group of pathologies, such as polyarteritis, 
sarcoidosis, Sjöngren´s syndrome, leper, amiloidosis, Lyme disorder or HIV [127, 128]. 
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Inflammatory neuropathies do not occur frequently. However, it is very important to 
diagnose because they are treatable. Most known are Guillain-Barre´s syndrome, acute 
(AIDP) and/or chronic inflammatory demyelinating polyradiculoneuropathies (CIDP), 
multifocal motor neuropathy, Lewis-Sumner syndrome, Fisher syndrome and Bickerstaff 
brainstem encephalitis (last two types usually occur acutely and have clinical overlap with 
AIDP) [127]. 
The course of these neuropathies can be monophasic, relapsing, or progressive. Nerve 
conduction studies (NCS) have revealed features of demyelination, particularly motor 
nerve conduction block and temporal dispersion [127, 128]. 
 
6.4.9 – Neuropathy induced by medication 
Drug-induced neuropathy is caused primarily by patient´s usual medications. Although 
these neuropathies affect just 2 to 4% of individuals who take specific prescription 
medications, there are many concerns regarding the resulting symptoms. Drug therapy for 
pain treatment appears to be very frustrating for many patients [129].  
There are numerous powerful drugs that have great potential to generate severe side 
effects. These drugs have shown to induce neuropathy, being classified in seven wide 
categories: chemotherapy drugs, antifungal drugs, antibiotics, drugs involved in the 
treatment of infectious disease, cardiovascular and cholesterol drugs, hypnotics, and 
psychotherapeutic drugs used especially to treat addictions [129-132]. 
Numerous iatrogenic neuropathies are due to specific medications, exceptionally 
prescribed, such as disulfiram, perhexiline, almitrine (usually used in small doses with 
minimal toxicity), phenytoin, ara-C, or metronidazole (habitually used for short period) 
[129, 130]. 
There are several drugs that produce endurable neuropathies, because the primary 
disease is extremely severe, mostly malignancies and HIV infection. In these particular 
cases evolving research has been aimed to identify secondary agents or delivery methods 
to reduce or prevent toxicity [129, 130]. 
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Toxic effects are simpler to recognize when acute or sub-acute onset of symptoms occurs 
shortly after the first drug exposure or a change of medication dosage. On the contrary, it 
is much more difficult to identify the symptoms for diagnosing a gradually progressive 
neuropathy after several months or even years after starting a chronic medication with 
constant doses [129-131]. 
 
6.5 – Electrophysiological measurements and nerve conduction studies (NCS) 
All subjects involved in our study were assessed with surface electromyography (EMG), a 
non-invasive technique that consists in applying cutaneous electrodes to the skin surface 
for studying muscle and nerve characteristics. EMG is basically a graphical recording 
method (Figure 10) of muscle nerve action potentials, being frequently used for testing the 
muscle and motor nerve fiber activities (as described previously in Chapter 3), allowing a 
more precise evaluation of the severity degree of diabetic neuropathy [133].  
EMG is a modern clinical method of investigation that in many cases complements 
effectively the medical examination. In our case, electrophysiological examinations were 
performed for evaluating the severity (distinguishing precisely between mild and 
moderate degree) and monitoring significant injuries and progressions of DPN. In 
summary, EMG aimed to add a superior level of specificity to the diagnosis [133]. 
Surface EMG represents a common method of measurement, especially due to its non-
invasiveness and simplicity, since it can be accomplished by personnel other than medical 
doctors, with smallest risk to the subject. Nevertheless, to ensure the maximum safety of 
all subjects involved in our study, all measurements were performed by an experienced 
neurophysiologist of the Department of Neurology of Coimbra University Hospitals, and 
were conducted according to guidelines of the Declaration of Helsinki and submitted to 
approval by the Medical Ethics Committee of the Faculty of Medicine, Coimbra University. 
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Electrophysiological measurements were performed using a Nicolet Biomedical EA4 
(Nicolet Biomedical, Inc, USA) recording device. The measured signal, called 
electromyogram, was obtained by applying conductive electrodes to the skin surface. The 
neurophysiologist placed carefully small electrodes on specific leg surface sites, including 
the ankle, fibular head and popliteal fossa, and used a stimulator, that applies low 
amplitude current pulses (that do not cause any hazard to the body), for delivering a 
controlled electrical current to subjects’ skin, forcing the assessed nerves to respond with 
electric pulses, resulting in EMG signals. These electrical signals, produced by the nerves, 
were instantly collected by the computer, and the measurement information (Figure 10) 
was interpreted by the same examiner [133]. 
Figure 10 – Sample of surface EMG signals from a diabetic subject, corresponding to: a) right 
peroneal nerve; b) sympathetic nerve response; c) right and d) left sural nerve. [CHUC, Department 
of Neurology, EMG and EP Lab; measurement performed in May, 2012], [133] 
b a 
c d 
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EMG measurements comprised nerve conduction evaluation, assessing motor (peroneal) 
and sensory (sural) NCV and amplitudes, as well as cutaneous sympathetic response 
measurement.  
 
Surface EMG signal is based on amplitude and time and frequency domain properties, 
which depend on a number of factors [134], such as:  
• Timing and intensity of muscle contraction/nerve impulse (in our case) 
• Distance between electrode and the tested nerve 
• Properties of the overlying tissue (such as thickness of overlying skin, muscle and adipose 
tissue) 
• Electrode and amplifier properties 
• Quality of contact between the applied electrode and the skin surface [134] 
 
 
6.6 - CCM image acquisition 
All CCM images were obtained at the Department of Ophthalmology of the Coimbra 
University Hospitals. These images were collected using a Heidelberg Retinal Tomograph 
equipped with a Cornea Rostock Module (HRT-CRM:  Heidelberg Engineering, Heidelberg, 
Germany). The device that we used to scan and examine the corneal area is a Laser-
Scanning Confocal Microscope (LSCM), which illuminates the corneal structures using a 
visible 670-nm red wavelength diode laser [135]. 
Confocal scans were recorded over a depth varying between 30-50 μm. The 384 x 384 
pixels images correspond to a 400 μm x 400 μm area and were saved as JPEG images. 
Several sample images are shown in Figure 11.  
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As previously mentioned in the first chapter, the normal human cornea consists of five 
avascular layers: corneal epithelium, Bowman’s layer, stroma, Descemet’s membrane and 
corneal endothelium. With the exception of Descemet’s membrane, all corneal layers can 
be easily shown by IVCCM. The resolution and magnification capacity of the confocal 
microscope used in our study allowed us to obtain images of different corneal layer cells, 
with good quality. 
All CCM measurements were supervised by an experienced ophthalmologist and were 
conducted according to guidelines of the Declaration of Helsinki and submitted to approval 
by the Medical Ethics Committee of the Faculty of Medicine, Coimbra University. In short, 
the measuring procedure consisted in applying topical anesthetic and a viscous tear gel to 
the subjects’ eyes to facilitate and ensure a sterile optical contact between the corneal 
epithelium and disposable cap on the objective lens of the confocal microscope. The gel 
Figure 11 – IVCCM (384 x 384) pixel images of the healthy living cornea, illustrating a) three different 
corneal layers (starting from the bottom): basal epithelium, Bowman’s layer and stroma; b) basal 
epithelium; c) sub-basal nerve plexus with corneal nerves; d) anterior stroma; e) mid-stroma (with less 
cells), and f) endothelium. [Images obtained at the Coimbra University Hospitals, Department of 
Ophthalmology; February 2012], [135] 
b c 
f e d 
a 
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also helped to match the refractive index between the objective lens and the cornea 
decreasing, therefore, losses by reflection that would be present at an air-tear film 
interface. Patients and volunteers were gently asked to fix their sight on a target placed 
behind the CCM device and the examiner used a side-view digital video camera to make 
certain that the apex or the central area of the cornea was entirely scanned. The CCM lens 
was manually focused on the sub-basal nerve plexus of the cornea by the ophthalmologist, 
which carefully captured the high-contrast images that best illustrated the corneal nerves 
[135]. 
All individuals included in our research study underwent a bilateral examination of the 
corneal nerve fibers. We used the section mode to capture images from the cornea, 
acquiring only those that illustrate clearly the corneal nerves. The section mode refers to 
the option of capturing manually single images (without automatic image capture during 
axial scanning). This method requires particular focus on nerve fibers, followed by a 
qualitative choice as to which fibers to show in the obtained image [135]. 
 
6.7 – Standard Operating Procedure (Image Analysis: Morphometric parameters) 
For the automatic processing and image analysis was initially used a larger set of 200 
images (20 sub-sets of 10 bilateral images, corresponding to one sub-set per individual), 
containing 5 best IVCCM images for each eye (i.e., 10 images per individual that contain 
only nervous structures, allowing a clear differentiation between the main corneal nerve 
trunks and secondary nerves, or ramifications) of sub-basal nerve plexus for each subject. 
The final selection procedure consisted in choosing one image from the set of these 5 best 
quality images per eye during visual inspection by the examiner on post examination 
analysis. The selection of this image was based on the combination of five qualitative 
criterions (including three parameters): highest density of nerve fibers (NFD), maximum 
length of nerve fibers (NFL), and highest density of branching (NBD); best image features 
(well-focused and high contrast image) and maximum sensitivity of automatic nerve 
detection. 
 
Evaluation of Corneal Nerve Morphology for Detection and Follow-up of Diabetic Peripheral Neuropathy 
75 
 
The identification of most relevant morphologic characteristics, as well as the evaluation 
of their suitability for the early detection and follow-up of DPN with CCM, included the 
following corneal parameters, observed within a frame: nerve fiber density (NFD), width 
(NFW) and length (NFL), nerve tortuosity (TC), as well as nerve branching density (NBD), 
branching pattern (NBP) and angle (NBA). This procedure was performed, as previously 
mentioned, in all images for each subject included in our study, with a calculated mean 
value for each of the identified parameter (described in details below). 
Nerve Fiber Density (NFD), the total number of count nerves per square millimeter of 
corneal tissue (number of fibers/mm2);  
Nerve Fiber Width (NFW), the computed average axe value for each of corneal nerves 
and/or segments, expressed in μm/mm2 (2 main axes, the minor axe corresponds to 
width, the major axe-length); 
Nerve Fiber Length (NFL), the total length of all nerve fibers and branches of corneal tissue 
expressed in mm/mm2; 
Tortuosity Coefficient (TC, parameter that quantifies if a structure is curved or winding, 
according to the definition proposed by Kallinikos et al.[93]), giving information on the 
frequency and magnitude of nerve curvature changes: 
 
 
Where N represents the number of pixels of the nerve skeleton, while f’ (xi, yi) and f’’ (xi, yi) 
are the first and second derivatives at the point (xi, yi), respectively. 
 
Nerve Branch Density (NBD), the number of branches emanating from main nerve trunks 
per square millimeter of corneal tissue (number of nerve branches/mm2); 
Nerve Branching Pattern (NBP), expressed as the percentage of branches per total 
number of nerve fibers; 
Nerve Branching Angle (NBA), mean value of the angle formed by the branches with 
respect to the main nerve trunk (where they start from). General orientations of a branch 
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can be horizontal (if the angle measured between 0o and 30o), oblique (between 31o and 
60o) or vertical (between 61o and 90o). 
The results obtained from segmented images with the algorithm developed by our team, 
were compared with the values of manually traced nerves by an experienced examiner 
using a commercial program, on the same images. The percentage of nerve length 
correctly and falsely detected was also calculated. 
 
6.8 – Corneal nerve segmentation algorithm 
The method used for the automatic extraction and analysis of sub-basal corneal nerve 
morphometric parameters is a segmentation algorithm implemented in MatLab, which 
was applied to a set of 200 images (as mentioned before, corresponding to 10 bilateral 
corneal images per subject involved in the study).  
This automated method was already described in previous publications [136]. It starts by 
normalizing the image contrast and reducing the noise, using contrast equalization, a 
phase symmetry-based method and histogram procedure. Subsequently, a quick search is 
done to find candidate regions that are expanded to recognize corneal nerve fibers. False 
positives are discarded, whilst all remaining results are joined for an improved 
identification of complete nerve structure and distribution. 
 
6.8.1 - CCM image: artifacts 
Generally, CCM images captured and recorded with good quality show well-defined nerve 
fibers. These fibers usually appear as connected structures. Nevertheless, many images 
obtained in our study were affected by noise and the presence of small curvilinear 
structures (such as tissue deformities and artifacts), typically manifested as unclear and 
disoriented small fragments. These undesired structures complicated the extraction of 
nerve fibers. Only after noise reduction the nerve fiber segmentation and extraction 
becomes an easier task, providing better information for the post-processing stages.  
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Types of artifacts 
During the CCM image acquisition process, a low number of images were also affected by 
several types of artifacts, such as saccadic eye movement (which usually resulted in 
motion or blurring effects of the nerve fibers), nerves located at different depths (causing 
deeper nerve fibers to appear very faint), focusing in or out of the sub-basal plexus plane 
(manifested as nerve fiber fluctuations - appear and disappear, affecting also the visual 
diameter and the brightness of the nerve fiber), illumination artifacts (affects image 
brightness and contrast) or the presence of small undesired bright structures (usually basal 
epithelial cells or keratocytes and nerve deformities). Several representative examples of 
noise and/or artifacts are represented in Figure 12 [135].  
 
 
 
 
 
6.8.2 – Segmentation algorithm 
The segmentation algorithm used in our study is implemented in a Matlab™ code named 
Cornea3 and encompasses three main steps: 1) local equalization, for improving image 
details; 2) phase symmetry, using wavelet transform filter, to recognize the nerves 
structures; and 3) nerve reconstruction, using morphologic operations [136]. 
 
Figure 12 – Representative examples of CCM image artifacts and noise, with: a) corneal tissue 
deformity; b) illumination artifacts and blood vessel; c) blurring effect from saccadic eye 
movement; d) bright structures; e) stromal cells; f) depth differences and bright structures; g) 
and h) illumination artifacts. [Images obtained during several IVCCM image acquisition 
sessions, 2012], [135] 
a c b d 
e f g h 
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Local equalization  
Images obtained through CCM reveal corneal nerves identified as bright well-defined and 
mostly connected linear structures over a dark background. This background is typically 
characterized by an intensity variation. For this reason, it is essential to correct this non-
uniformity. Histogram equalization is usually required for enhancing the image contrast 
[137].  
Cornea3 involves a contrast-limited adaptive histogram equalization method, which uses 
information from numerous histograms corresponding to several small image areas. The 
contrast is restricted to a limit value, in order to avoid increase in image noise, particularly 
in homogeneous regions. The current method was applied using an 8 × 8 pixel square 
mask [136]. 
 
Phase symmetry 
Symmetry is an essential mechanism to identify the structure and shape of objects. 
Knowing the symmetry we can specify the invariance of objects under geometric 
transformations. There are different image features, such as lines, ridges, valleys and blobs 
that have distinct phase responses. To acquire local phase frequency information, the 
algorithm included a methodology based on wavelet transform filters, namely log-Gabor 
filters [136].  
This methodology involves two filters: a first filter for calculating the amplitude and a 
second one for the signal phase, for a specific scale and frequency, at a certain spatial 
location. Both filters can be preset with arbitrary bandwidth. The phase-shift procedure 
included six orientations for symmetry searching and produced enhanced images with 
highlighted tubular structures that clearly show the nerves location [136]. 
 
An example of the output images after the first two steps (local equalization and phase 
symmetry) of the algorithm is presented in Figure 13 [138]. 
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Nerve Reconstruction 
This final step consists in a complete reconstruction of the corneal nerves, based on 
tubular structures recognized by the phase symmetry step. It starts with a selection of 
correct seed points, being complemented with a rejection step. The algorithm analyzes the 
segmented image, excluding inappropriate structures with incompatible features (i.e., 
features that do not correspond to corneal nerves) [136]. 
The selection procedure is performed by computing the skeleton of the image, 
establishing whether a nerve branch is accepted or discarded. The computed skeleton 
allows the identification of isolated or disconnected segments. Usually, isolated structures 
are excluded, since they correspond to non-nerve region or noise. In many cases, stromal 
keratocytes (cells situated at layers posterior to the sub-basal nerve plexus) are the 
isolated structures to be rejected [136]. Example results of the nerve reconstruction step 
are shown in Figure 14 [138]. 
 
 
 
Figure 13 – Representation of the two initial steps of Cornea3 segmentation algorithm applied 
to CCM images: a) original image, b) local equalization step, and c) phase-shift step. [Results 
obtained in July, 2012], [138] 
a 
Figure 14 – Representative sample images and obtained results after the nerve reconstruction step: a) 
original CCM image, b) reference image (manually delineated), c) segmented image and d) 
reconstructed nerves. [Results obtained in July, 2012], [138] 
a
) 
b c 
b
) 
c
) 
d
) 
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6.9 – Statistical methods 
 
SPSS Statistics (version 17.0) was used to compute the results of each morphometric 
parameter. Data are presented as means ± standard deviation. ANOVA with Tukey´ post 
hoc tests were used to establish differences among the four groups (control, none, mild, 
and moderate DPN) if the data followed a normal distribution. Otherwise the Kruskal-
Wallis test with nonparametric between group comparisons using the Nemenyi test was 
used. A significance level of 0.05 was taken in all cases. Pearson correlation tests were 
used to analyze the existing correlations between the morphometric parameters and 
other variables. Additionally, box-plots, scatter-plots and drop-line charts were used to 
represent graphically specific results.  
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SECTION IV 
 
RESULTS 
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CHAPTER 7 – RESULTS ANALYSIS 
 
As mentioned before, all participants involved in our study were divided in four main 
groups, according to their DPN severity: control, absent, mild and moderate DPN 
(summarized in Table 7). 
Table 7 – Summary of the four participants groups (baseline evaluation). 
DPN Group  
(severity 
degree)  
Number of 
Subjects 
Mean Age ± 
St. dev. 
(years) 
Bilateral CCM 
Images 
MNSI 
Questionnaire 
(0-15) 
MNSI 
Scoring 
(0-10) 
EMG 
diagnosis 
Control 8 54 ± 7 80 0 0 Normal 
Absent  4 53 ± 11 40 0-3 0-1 Normal 
Mild  5 58 ± 9 50 4-6 2-3,5 
DPN or 
Normal 
Moderate 3 60 ± 9 30 6-8 2-3 DPN 
 
The automatic algorithm (Cornea3) was evaluated comparing the results obtained with 
manually traced nerves, by an experienced examiner using a commercial program. The 
percentage of nerve length (expressed in pixels) correctly and falsely detected was 
calculated. Results are shown in Table 8, where the sensitivity represents the proportion of 
actual positives which are correctly identified: 
                        
                                                  
 . 
 
Table 8 – Descriptive statistics: evaluation of the segmentation algorithm performance. 
Variable Minimum Maximum Average 
Standard 
Deviation 
Nerve length correctly detected 
(true positives) (%) 
19,9 91,0 56,7 20,3 
Nerve length falsely detected (false 
positives ) (%) 
0 2,1 0,5 0,8 
Sensitivity (%) 19,3 91,0 57,1 20,4 
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7.1 – Nerve fiber density (NFD) 
NFD represents the total number of count nerves per square millimeter of corneal tissue, 
expressed in number of nerve fibers / mm2. The results are summarized in Table 9, and 
graphically shown in Figure 15. Boxplots show the median, interquartile range, outliers, 
and extreme cases of individual variables. 
Table 9 – NFD for automatically segmented and manually delineated images. 
NFD: mean value ± st. dev. (count nerves / mm2) 
Groups 
Automatic 
algorithm 
Manually traced 
nerves 
Control 44,5 ± 31,8 122,3 ± 49,3 
Absent 33,6 ± 22,6 87,5 ± 54,7 
Mild 20,0 ± 12,0 50,6 ± 9,7 
Moderate 19,8 ± 7,9 41,7 ± 23,7 
 
  
 
 
ANOVA with Tukey´ post hoc tests have shown differences only for manually traced 
nerves, among the following groups: Control and Mild; Control and Moderate, with mean 
Figure 15 – Representative boxplots (with median, interquartile range, outliers, and 
extreme cases of individual variables) of NFD parameter in a) segmented images by the 
algorithm, and b) manually traced nerves. [Results obtained in August, 2012] 
a b 
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difference significant at 0.05 level. No significant differences were found for automatically 
segmented nerves. 
 
7.2 – Nerve fiber width (NFW) 
NFW represents the computed average axe value (in pixels) for each of corneal nerves 
and/or segments, expressed in μm/mm2. The results were obtained only for automatic 
images, given that manually traced nerves have all the same width (3 pixels). The values 
are shown in Table 10 and Figure 16. 
 
Table 10 – NFW for automatically segmented nerves. 
NFW: mean value ± st. dev. (μm/mm2) 
Groups Automatic algorithm 
Control 7,9 ± 1,3 
Absent 8,4 ± 2,5 
Mild 9,6 ± 1,1 
Moderate 9,5 ± 1,0 
 
   
 
 
 
ANOVA with Tukey´ post hoc tests have not shown any significant difference for automatic 
detected nerves, among the existing groups. 
Figure 16 – a) Representative boxplot (with median, interquartile range, outliers, and 
extreme cases of individual variables) and b) scatterplot of NFW parameter in segmented 
images by the algorithm. [Results obtained in August, 2012] 
a b 
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7.3 - Nerve Fiber Length (NFL) 
NFL is the total length of all nerve fibers and branches of corneal tissue, expressed in 
mm/mm2. The results are summarized in Table 11, and schematically shown in Figure 17. 
 
Table 11 – NFL for automatically segmented and manually delineated images. 
 NFL: mean value ± st. dev. (mm/mm2) 
Groups Automatic algorithm Manually traced nerves 
Control 8,9 ± 5,3 14,6 ± 3,9 
Absent 7,2 ± 5,1 10,7 ± 4,1 
Mild 4,8 ± 2,7 8,8 ± 1,0 
Moderate 4,6 ± 2,6 6,9 ± 3,2 
 
 
 
 
 
 
ANOVA with Tukey´ post hoc tests have shown differences only for manually traced 
nerves, among the following groups: Control and Mild DPN; Control and Moderate DPN, 
with mean differences significant at 0.05 level. No significant differences were found 
between diabetic groups. 
 
 
Figure 17 – Representative boxplots (with median, interquartile range, outliers, and 
extreme cases of individual variables) of NFL parameter in a) segmented images by the 
algorithm, and b) manually traced nerves. [Results obtained in August, 2012] 
a b 
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7.4 – Tortuosity Coefficient (TC) 
 
TC provides information on the frequency and magnitude of nerve curvature changes. To 
calculate this parameter is necessary to “consider each nerve as a mathematical function 
on the image space and compute the function first and second derivatives” [93, 135].  
 
N represents the number of pixels of the nerve skeleton, while f’ (xi, yi) and f’’ (xi, yi) are 
the first and second derivatives at the point (xi, yi), respectively. The results are 
summarized in Table 12, and schematically shown in Figure 18. 
 
Table 12 – TC for automatically segmented and manually delineated images.  
TC: mean value ± st. dev. 
Groups 
Automatic algorithm 
Manually traced 
nerves 
Control 52,6 ± 72,8 14,2 ± 2,4 
Absent 179,7 ± 227,4 34,1 ± 39,3 
Mild 36,4 ± 34,1 23,6 ± 18,7 
Moderate 53,7 ± 40,9 25,2± 13,6 
 
 
 
 
Figure 18 – Representative boxplots (with median, interquartile range, outliers, and 
extreme cases of individual variables) of TC parameter in a) segmented images by the 
algorithm, and b) manually traced nerves. [Results obtained in August, 2012] 
a b 
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In both cases, automatic and manually traced nerves, ANOVA with Tukey´ post hoc tests 
have not shown any significant difference among the existing groups. 
 
7.5 – Nerve Branch Density (NBD) 
NBD represents the number of branches emanating from main nerve trunks per square 
millimeter of corneal tissue, expressed in number of nerve branches/mm2. The results are 
summarized in Table 13, and schematically shown in Figure 19. 
Table 13 – NBD for automatically segmented and manually delineated images. 
NBD: mean value ± st. dev. (branches/mm2) 
Groups 
Automatic algorithm 
Manually traced 
nerves 
Control 23,0 ± 26,2 88,3 ± 53,6 
Absent 18,0 ± 24,0 63,3 ± 61,2 
Mild 3,1 ± 7,0 28,1 ± 7,3 
Moderate 4,2 ± 4,8 22,9 ± 26,2 
 
     
 
 
As for the previous parameter (TC), in both automatic and manually traced nerves, ANOVA 
with Tukey´ post hoc tests have not shown significant differences between the existing 
groups. 
Figure 19 – Representative boxplots (with median, interquartile range, outliers, and 
extreme cases of individual variables) of NBD parameter in a) segmented images by the 
algorithm, and b) manually traced nerves. [Results obtained in August, 2012] 
a b 
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7.6 – Nerve Branching Pattern (NBP) 
NBP represents the ratio between nerve branches density and nerve fibers density, 
expressed as the percentage of branches per total number of nerve fibers within a single 
frame. The results are summarized in Table 14, and schematically shown in Figure 20. 
Table 14 – NBP for automatically segmented and manually delineated images. 
NBP: mean value ± st. dev. (%) 
Groups 
Automatic algorithm 
Manually traced 
nerves 
Control 35,3 ± 27,3 66,3 ± 19,6 
Absent 32,6 ± 26,9 60,9 ± 22,7 
Mild 7,9 ± 17,6 49,5 ± 11,6 
Moderate 15,6 ± 15,0 40,8 ± 23,8 
 
     
 
 
 
ANOVA with Tukey´ post hoc tests have not shown any significant difference among the 
existing groups for automatic detected nerves, as well for manually traced nerves.  
 
 
Figure 20 – Representative boxplots (with median, interquartile range, outliers, and 
extreme cases of individual variables) of NBP parameter in a) segmented images by the 
algorithm, and b) manually traced nerves. [Results obtained in August, 2012] 
a b 
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7.7 – Nerve Branching Angle (NBA) 
NBA represents the mean value of the angle formed by the branches with respect to the 
main nerve trunk (where they start from). General orientations of a branch can be 
horizontal (if the angle measured between 0o and 30o), oblique (between 31o and 60o) or 
vertical (between 61o and 90o). The obtained results are shown in Table 15, and 
schematically illustrated in Figure 21. 
 
Table 15 – NBA for automatically segmented and manually delineated images. 
NBA: mean value ± st. dev. (degrees) 
Groups 
Automatic algorithm 
Manually traced 
nerves 
Control 41,1 ± 24,2 34,0 ± 25,0 
Absent 84,5 ± 39,3 25,5 ± 6,2 
Mild 12,34 ± 0* 26,9 ± 28,1 
Moderate 20,8 ± 9,0 16,8 ± 1,8 
  
    
 
 
Once more, in both automatic and manually traced nerves, ANOVA with Tukey´ post hoc 
tests have not shown any significant difference among the existing groups.  
 
Figure 21 – Representative boxplots (with median, interquartile range, outliers, and 
extreme cases of individual variables) of NBA parameter in a) segmented images by the 
algorithm, and b) manually traced nerves. [Results obtained in August, 2012] (*NBA 
value was considered valid only for one individual with Mild DPN)  
a b 
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7.8 – Electrophysiological findings 
EMG measurements involved nerve conduction evaluation, including motor and sensory 
nerves conduction velocities (NCV) and amplitudes, as well as cutaneous sympathetic 
response assessment. As mentioned in Chapter 3, NCS represent valuable measures, 
especially for the assessment of damage degree in larger nerve fibers in a trustworthy and 
objective way. These tests are typically demanded by a neurophysiologist for evaluating 
the muscle or nerve damage (when necessary), representing an important part of a 
medical workup. The obtained results are shown in Table 16, and schematically illustrated 
in Figures 22-23. 
 
Table 16 – Electrophysiological measurements.  
 
NCS Results: mean ± st. dev. 
 Motor nerve Sensory nerve Cutaneous 
Groups NCV (m/s) 
Amplitude 
(μV) 
NCV (m/s) 
Amplitude 
(μV) 
Sympathetic 
response (s) 
Control 46,8 ± 2,2 5,1 ± 2,0 47,9 ± 3,5 18,0 ± 6,7 1,98 ± 0,12 
Absent 43,9 ± 2,4 3,5 ± 1,2 43,9 ± 4,4 12,3 ± 5,5 1,86 ± 0,35 
Mild 44,1 ± 4,4 4,4 ± 3,0 46,5 ± 5,6 12,9 ± 2,2 2,16 ± 0,35 
Moderate 38,3 ± 5,3 2,4 ± 1,0 43,0 ± 6,4 5,2 ± 2,9 1,89 ± 0,01 
 
      
 
Figure 22 – Representative boxplots (with median, interquartile range, outliers, and 
extreme cases of individual variables) with nerve conduction velocities for a) motor 
nerve, and b) sensory nerve. [Results obtained in August, 2012] 
a b 
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ANOVA with Tukey´ post hoc tests have shown significant differences (at 0.05 levels) for 
motor NCV and sensory nerve conduction amplitude, among the following DPN groups: 
Moderate and Control.  
Although controls differ substantially from diabetic groups, statistical tests have not 
revealed any significant difference between the existing groups for the sensory NCV, as 
well as for the sympathetic response. However, sensory NCV and amplitudes were 
established by the neurophysiologist as abnormal (below the limit) in patients with 
moderate degree of DPN, because these patients have shown the lowest values of motor 
Figure 23 – Representative boxplots (with median, interquartile range, outliers, and 
extreme cases of individual variables) with nerve conduction amplitudes (expressed in 
μV) for a) motor nerve, b) sensory nerve, and c) sympathetic nerve response (latency 
time [ms]).  [Results obtained in August, 2012] 
a b 
c 
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and sensory NCV, showing also the lowest motor and sensory amplitude values, in 
comparison to mean values of the remaining groups.  
NCS have also shown that patients with moderate DPN have a significant axonal loss, 
demonstrated by decreased motor amplitudes (CMAP) and reduced sensory amplitudes 
(SNAP). The low values of both motor and sensory NCV indicate that moderate DPN cases 
occur with severe nerve demyelination (as explained in Section I, Chapter 3). 
 
7.9 – Correlations tests and distribution charts for manually segmented nerves 
This section contains representative scatter-plots and results of the correlation tests only 
for manually delineated nerves, since all parameter values are more accurate, when 
compared to automatic segmented nerves.  
Pearson correlation tests, with a factor ranging between 0 and 1 (minimum and maximum, 
respectively) have revealed a strong correlation, significant at the 0.01 level (sig. 2-tailed) 
between the following morphometric parameters:  NFD, NFL, NFW, NBD and NBP. 
Additionally, Pearson correlation tests have shown correlations, statistically significant, 
between NFD, NFL and motor NCV (summarized in Table 17).  
Table 17 – Summary of correlation tests between morphometric parameters. 
Parameters 
Pearson correlation factor at p<0.01 level  
NFD NFL NFW NBD NBP motor NCV 
NFD - 0,916 -0,752 0,983 0,862 *0,487 
NFL 0,916 - -0,732 0,896 0,859 0,578 
NFW -0,752 -0,732 - -0,767 -0,763 - 
(*) - p<0.05 level 
No significant correlations were found between TC and other parameters, as well as NBA, 
sensory NCV and sympathetic response. These parameters do not depend on the variation 
of other parameters, mentioned above. 
NFD represents an important parameter, which is strongly correlated with several other 
parameters. NFD is inversely correlated with NFW, and directly correlated with NFL, NBD, 
NBP, and motor NCV, indicating that a higher density of the nerve fibers is directly 
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proportional with increased nerve length and richer branching pattern, resulting in a faster 
conduction velocity (as shown in Figure 24). 
  
  
  
 Figure 24 – Representative scatterplots showing the distribution of individuals 
according to NFD and a) NFW; b) NFL; c) NBD; d) motor NCV; e) sensory 
amplitude; and f) motor amplitude [Results obtained in August, 2012] 
a b 
c d 
e f 
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Other important parameter is NFL, also significantly correlated with several parameters. 
NFL is inversely correlated with NFW, while directly correlated with NFD, NBD, NBP and 
motor NCV, suggesting that longer nerve fibers are faster conducting and directly 
proportional with higher nerve density and richer branching pattern (Figures 24(a) and 25).  
 
  
 
 
 
NFW is also an essential parameter, which appears to correlate inversely with numerous 
other parameters, such as NFD, NFL, NBD and NBP. This fact demonstrates that reduced 
length and number of nerve fibers, as well as decreased branch density induce an increase 
of nerve width (Figure 26). 
Figure 25 – Representative scatterplots showing the distribution of individuals 
according to NFL and a) NBD; b) NFW; c) NBP; and d) sensory amplitude. 
[Results obtained in August, 2012] 
a 
c 
b 
d 
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Other morphometric parameters, such as TC and NBA, have not exhibited any correlation. 
Next scatter charts show the distribution of the subjects according to these last three 
parameters, where is obvious that the obtained values are widely distributed, in a 
“chaotic” and incosistent manner, showing that these parameters do not follow same 
distribution rule, between and within groups, as NFD and NFL parameters. TC and NBA 
provide inconclusive information on the presence and/or severity degree of DPN (Figure 
27).  
Figure 26 – Representative scatterplots showing the distribution of individuals 
according to NFW and a) NFD; b) NFL; c) NBD; and d) NBP. [Results obtained in 
August, 2012] 
c 
a b 
d 
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Figure 27 – Representative scatterplots showing the distribution of individuals 
according to; a) TC and NBA; b) NBP and TC; c) NFL and TC; and d) NFL and NBA 
[Results obtained in August, 2012] 
a b 
c d 
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SECTION V 
 
OVERVIEW 
RELEVANCE OF THE STUDY 
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CHAPTER 8 – DISCUSSION AND CONCLUSIONS 
 
Our study aimed principally to evaluate the ability of detecting and quantifying DPN using 
the morphology of corneal nerves measured in CCM images. In particular, we intended to 
assess the ability to differentiate between several groups of individuals, including healthy 
volunteers and diabetics type 2 (insulin-treated), divided according the presence/absence 
and severity degree of DPN, using numerical parameters related to corneal nerves 
morphology. 
 
In this work I have presented two different sets of results. First set was obtained using a 
fully automatic segmentation algorithm for identifying corneal nerves in CCM images. 
Second set was obtained from manually traced images by an experienced examiner, using 
a commercial program. I evaluated the algorithm performance in a set of 40 bilateral 
images of the sub-basal nerve plexus of 8 healthy (non-diabetic) and 12 diabetic 
individuals. This set was extracted during visual inspection by the examiner on post 
examination analysis, from a larger set of 200 images (10 bilateral images per individual). 
The selection was mainly based on choosing best quality images (analyzing several 
quantitative and qualitative criterions, such as higher NFD, NFL, NBD and automatic 
detection performance) in order to have a set representative of the images obtained by an 
ophthalmologist with experience on CCM. 
 
The study consisted in a detailed evaluation of a small cohort of healthy controls and type 
2 diabetic patients with different degrees of neuropathy severity according to MNSI 
classification (absent, mild and moderate; no patients with severe neuropathy were 
identified). We found that CCM can be successfully used as a complementing technique for 
the clinical and electrophysiological diagnosis of DPN, as defined by consensus criteria 
using nerve conduction studies (NCS). 
 
We have started by grading DPN in diabetic patients, according to the presence of distal 
symmetrical symptoms assessed by neurological examination (MNSI scoring and 
questionnaire), abnormal NCV assessed by electrophysiological measurements, clinical 
outcomes of small fiber abnormalities (with emphasis on presence of corneal nerve length 
and density dependent symptoms) quantified by CCM. 
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As would be expected, our study has shown that DSPN is one of the most frequent diabetic 
neuropathies (patients with moderate neuropathy were diagnosed with DSPN), affecting 
both sensory and motor nerves. NCS examinations have validated that DSPN is mainly 
axonal with a predominantly large diameter nerve fiber involvement. NCS quantified large-
fiber abnormalities in all patients with moderate degree of neuropathy, and in one patient 
with mild degree, establishing DSPN diagnosis. Electrophysiological measurements have 
shown progressive axonal losses (according to the DPN severity), by exhibiting decreased 
amplitudes of the compound muscle action potential (CMAP), decreased sensory nerve 
action potential (SNAP), reduced motor and sensory nerve conduction velocities (NCV), 
whilst CCM have quantified small fiber disorders (gradual reduction in corneal NFD, NBD 
and NFL), showing that DSPN also occur with mixed large - and small diameter nerve fiber 
involvement. 
 
On the other hand, NCS have shown normal NCV values (considered by the 
neurophysiologist) for all patients without DPN and for the majority of the patients with 
mild degree of severity. Nevertheless, the NCV and amplitude values for both motor and 
sensory nerves were lower for the patients with mild DPN, while CCM quantified 
accurately small fiber pathology (decreased NFD and NFL) in mild DPN patients, which did 
not seem to have larger nerve fiber injuries.  
 
Although CCM is still in early phase of development and employment as a potential marker 
of diabetic neuropathy, the application of this non-invasive technique allowed us to obtain 
promising results. Once more, CCM has shown to be valuable (at least as a complementing 
diagnostic tool), providing useful information in order to stratify patients’ neuropathic 
severity, confirming also the MNSI classification. We were able to distinguish the controls 
from diabetics, to differentiate individuals without DPN from those with DPN, and most 
important, to stratify the patients according to the MNSI classification for the severity of 
neuropathy. The outcomes from our observational study have clarified the true efficacy 
CCM, confirming and showing similar results to prior studies.  
 
The parameters that have shown a good quantification and diagnostic potential 
performance were NFL, NFD, NFW and NBD, and consequently NBP. NFL and NFD are the 
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parameters that revealed significant mean value differences between and within the 
control and diabetic groups, with high degrees of specificity and sensitivity. As described in 
several prior publications [70, 91, 92, 95-98, 103], NFD and NFL are significantly lower in 
diabetics compared to controls (p<0.05), establishing inverse correlations with severity 
degree of DPN. It is important to mention that both parameters revealed differences 
statistically significant (p<0.05) between controls and diabetics, between no DPN cases 
and DPN patients, and most important, within diabetics (MNSI mild and moderate groups) 
and healthy controls.  
 
NBD, NBP and NFW have not shown significant mean value differences between the MNSI 
groups, revealing instead differences that were statistically significant (p<0.05) between 
controls and diabetics, confirming the results published by Mocan et al. [96]. Moreover, 
diabetic patients have shown a gradual increase in nerve thickness (NFW) and a 
progressive reduction in nerve branching (NBD), according to their severity degree, as 
shown by Quattrini et al. [97] and Edwards et al. [103], respectively. 
 
TC and NBA parameters were the only parameters that have not revealed significant 
differences from statistical point of view, a result also reported by Ahmed et al. [101]. 
Nonetheless, we found in diabetics a general increase in tortuosity, as mentioned by 
Dabbah et al. [8] and Mocan et al. [96]. As for the NBA parameter, the results have shown 
inconsistent fluctuations between and within diabetic and control groups, being 
considered as inconclusive discrimination results. We conclude that the orientation angles 
of nerve branches do not depend on the presence or absence of DPN. NBA parameter 
have not shown any correlation with other parameters, a fact that demonstrates that the 
angle of nerve branching varies with non-correlated patterns between different 
individuals, independently of their diabetic and neuropathic status, or their nerve 
characteristics and parameters. 
 
Resuming, we were able to demonstrate that corneal small nerve fiber abnormalities are 
directly related to the severity of peripheral neuropathy. The accurate quantification of 
nerve fiber length and thickness (NFL and NFW, respectively), as well as nerve fiber and 
branch densities (NFD and NBD, respectively), allows us to conclude that an increasing 
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corneal nerve degeneration is directly related with increasing severity of diabetic 
neuropathy.  
 
NFL, NFW, NFD and NBD parameters allowed us to identify patients at initial phase of DPN 
(mild degree) that are at subsequent risk of developing clinically significant DPN (moderate 
and severe degree DPN). The mean difference values between diabetics with mild and 
moderate degree of DPN were minimal, proving that all four parameters are reliable 
predictors for neuropathic complications. 
 
A final conclusion can be made regarding the automatic detection and segmenting of 
corneal nerves, including two extremely important components: CCM images and 
computed algorithm (Cornea3). The results of automatically segmented nerves highlighted 
a number of technical insufficiencies and difficulties, including image quality (affected by 
artifacts), and algorithm performance (especially in nerve reconstruction and post-
processing steps).  
 
The algorithm performance was mainly affected by image artifacts, such as nerve 
discontinuities, motion or blurring effects of the nerve fibers, nerves located at different 
depths, focusing in or out of the sub-basal plexus plane, illumination artifacts (brightness 
and contrast) or the presence of small confounding bright structures (usually basal 
epithelial cells or keratocytes and nerve deformities). Although keratocytes should be 
rejected by phase symmetry, in some images they were not discriminated. Instead, they 
were mistakenly treated as secondary nerve branches.  
 
Consequently, the automated algorithm still requires a substantial and sophisticated 
improvement, especially in post-processing steps, in order to ensure the higher accuracy, 
reliability and consistency required for continuing this study. This improvement is 
particularly needed to upgrade the ability in handling nerve deformities and 
discontinuities, as well as discriminating confounding keratocytes. However, an 
encouraging aspect would be that, despite the insufficient sensitivity values of the 
automatic segmentation algorithm, we were able to obtain acceptable results for NFD, 
NFW, NBD and NFL parameters. These results allowed us to quantify noticeable 
differences between controls and diabetics.  
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CHAPTER 9 – FUTURE WORK 
 
The work done during this entire academic year has been truly interesting and challenging, 
revealing sometimes certain limitations, mainly regarding the participants’ selection and 
recruitment (principally due to DPN severity and age-matching factors), and technical 
difficulties, regarding the automatic analysis (nerve detection and segmentation). All these 
difficulties required for adequate solutions and gradual improvements, leading us to a 
better-structured and more efficient study. However, there are still few aspects related to 
our observational study that could be enhanced and, I have some suggestions for an 
eventual continuation of the project in the near future. 
 
My suggestions regard mainly the study duration and population recruitment. The 
duration of a larger trial for demonstrating efficiently a significant difference in outcomes 
between healthy volunteers (control population) and diabetic groups (according to DPN 
severity grading) is directly dependent on the desired statistical power of the study and 
relative success rates observed in both groups. This success rate depends directly on 
diabetic patients and controls recruitment.  
 
A future trial should recruit a minimum of 10 patients (ideal number would be 20) for each 
group, based on the severity of DPN symptoms (absent, mild, moderate and severe), 
summing a minimum of 40 diabetic individuals (better if 80), requiring for the same 
number of healthy individuals, selected carefully for an age and sex-matched study. The 
number of 10 patients per group provides the following least significant differences (LSD, 
based on the variance values obtained in our study): LSD = 33.4 fibers / mm2 for NFD 
parameter; LSD = 2.72 mm / mm2 for NFL parameter; and LSD = 36.5 branch / mm2 for NBD 
parameter. The recruitment of 20 patients per group is justified by lower LSD values, which 
in this case are significantly reduced (almost half of the initial values). Nonetheless, it is 
important to mention that LSD depends directly on variance, and lower the variance, 
lower the number of participants required for the study.  
 
Regarding the diabetics, the selection process should also consider the duration of DPN, as 
well the evolution of peripheral nerve complications. In healthy controls and patients with 
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absent, mild, moderate and severe neuropathy, neurological tests and additional 
assessment measures, such as nerve conduction studies (NCS) and QST, are sufficient to 
demonstrate a clinically meaningful and statistically significant difference, in less than one 
year.  
 
Another suggestion would be to perform an observational study, simultaneously in two 
different diabetic populations, with Diabetes Mellitus type 1 and type 2, respectively. In 
this case, with three different populations (type 1, type 2 and controls) with minimal 
numbers of 40 people for each population (summing a total of 120), could require more 
time (approximately 1 year) to demonstrate a clinically important and statistically 
significant mean difference between the stratified groups, according to the severity degree 
of DPN. 
 
A final suggestion would be to initiate a cross-sectional study for the evaluation of a 
population of type 2 diabetics, in order to assess and associate diabetic micro-vascular 
complications, namely diabetic retinopathy (both proliferative and non-proliferative, 
depending on the case), diabetic nephropathy and diabetic peripheral neuropathy (DPN). 
It would be extremely useful and interesting to associate and correlate nephropathy 
symptoms with retinopathy symptoms (such as presence micro aneurysms and 
neovascularization) and peripheral nerve abnormalities (decreased nerve fiber length and 
density and increased nerve fiber width), according to diabetic status and severity degree 
of all mentioned diabetic micro-vascular complications. 
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